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ABSTRACT 
 Atrial fibrillation (AF) is the most common arrhythmia after coronary artery bypass grafting 
(CABG). It is a significant source of morbidity, prolongs hospital stay and increases the costs of the 
treatment. Preoperative identification of patients at high risk of AF after CABG would be very 
helpful. Thus, the most effective prophylaxis should be focused on that group of patients. 
This study was performed to evaluate if patients at high risk of developing AF after CABG can be 
identified preoperatively or intraoperatively. The study consisted of four clinical trials. In the first 
study data of 3676 CABG patients were analysed and logistic regression model was created to 
predict the risk of postoperative AF. The negative and positive predictive value  of the model was 
0.72 and 0.55, respectively. In the second study analysis of heart rate variability (HRV) was 
measured preoperatively in 92 CABG patients in the standardised conditions. No measured 
parameters of HRV differed between the patients who got AF postoperatively and who remained in 
sinus rhythm. In the third study atrial sizes were preoperatively measured by echocardiography and 
atrial natriuretic peptide levels were analysed in 88 CABG patients. A large left atrial size was 
independent predictor of AF after CABG. High preoperative concentrations of atrial natriuretic 
peptides correlated with increased risk of postoperative AF, but there were not independent 
predictor of AF when adjusted for age. In the fourth study a new intraoperative high rate atrial 
pacing test was developed. Intraoperatively the right atrium was paced with high rate in order to test 
if AF was inducible. The pacing test was done for 80 patients undergoing CABG. The high-rate 
atrial pacing test induced AF in 27 patients. Of the 28 patients who experienced AF during 
postoperative period, 17 patients were inducible in the test. Positive and negative predictive values 
of the test were 0.63 and 0.79, respectively.   
Our study shows that intraoperative high-rate atrial pacing test is simple, safe and fast way to 
identify the patiens at risk for AF after CABG with a sufficient accuracy. Instead, the diagnostic 
accuracy of logistic regression model is not good enough for clinical use and also the analysis of 
HRV cannot identify the patients at high risk for AF after CABG. In addition, a large size of left 
atria is independent predictor of AF after CABG. 
 
Medical Subject Headings: arrhythmia; atrial fibrillation; myocardial revascularization; coronary artery 
bypass; risk assessment 
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SR Sinus rhythm 
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VLF Very low frequency 
  
LIST OF ORIGINAL PUBLICATIONS 
 
I Hakala T, Pitkänen O, Hippeläinen M. Feasibility of predicting the risk of atrial 
fibrillation after coronary artery bypass surgery with logistic regression model. Scand 
J Surg 2002; 91: 339-344. 
 
II Hakala T, Vanninen E, Hedman A, Hippeläinen M. Analysis of heart rate 
variability does not identify the patients at risk of atrial fibrillation after coronary 
artery bypass grafting. Scand Cardiovasc J. 2002; 36: 167-171. 
 
III Hakala T, Hedman A, Turpeinen A, Kettunen R, Vuolteenaho O, Hippeläinen 
M. Prediction of atrial fibrillation after coronary artery bypass grafting by measuring 
atrial peptide levels and preoperative atrial dimensions. Eur J Cardiothorac Surg 
2002; 22: 939-943. 
 
IV Hakala T, Berg E, Hartikainen JEK, Hippeläinen MJ. Intraoperative high-rate 
atrial pacing test as a predictor of atrial fibrillation after coronary artery bypass 
surgery. Ann Thorac Surg 2002; 74: 2072-2075. 
 
 
 
 
 
 
 
  
CONTENTS 
1. INTRODUCTION………………………………………………………13 
2. 2. REVIEW OF THE LITERATURE…………………….…………….14 
2.1. Atrial fibrillation after CABG 
2.1.1. Pathophysiology 
2.1.2. Incidence 
2.1.3. Clinical predictors 
2.1.3.1. Preoperative predictors 
2.1.3.2. Intraoperative predictors 
2.1.3.3. Postoperative predictors 
2.1.4. Impact on outcome and resource utilization 
2.1.5. Treatment 
2.1.6. Prevention 
2.1.6.1. Beta-blocking therapy 
2.1.6.2. Amiodarone therapy 
2.1.6.3. Magnesium substitution 
2.1.6.4. Other medical therapy 
2.1.6.5. Prevention by atrial pacing 
2.1.6.6. Posterior pericardiotomy 
2.2. Current methods for predicting the risk of atrial fibrillation after CABG 
2.2.1 Signal average P-wave ECG 
2.2.2. Standard electrocardiography 
2.2.3. Echocardiography 
2.3. Heart rate variability 
2.3.1. Heart rate variability as prognostic predictor in coronary heart disease 
2.3.2. Heart rate variability as predictor of atrial fibrillation in the recovery phase 
after CABG 
2.4. Atrial peptides 
  
2.4.1. Clinical importance of atrial peptides 
2.4.2. Atrial peptides and atrial fibrillation 
2.4.3. Atrial peptides and cardiopulmonary bypass 
2.5.           Intraoperative screening test    
3. AIMS OF THE PRESENT STUDY……………………………………44 
4. PATIENTS AND METHODS………………………………………….45 
4.1. Patients 
4.1.1. Study I 
4.1.2. Study II and study III 
4.1.3. Study IV 
4.2. Description of procedures 
4.2.1. Operative techniques 
4.2.2. Postoperative care and follow up 
4.3. Study settings 
4.3.1. Logistic regression model 
4.3.2. Analysis of heart rate variability 
4.3.3. Measurement of atrial sizes and concentrations of atrial peptides 
4.3.4. High-rate atrial pacing test 
4.4. Statistics 
5. RESULTS……………………………………………………………51 
5.1. Logistic regression model 
5.2. Analysis of heart rate variability 
5.3. Measurement of atrial sizes and concentrations of atrial peptides 
5.4. High-rate atrial pacing test 
6. DISCUSSION………………………………………………………..69 
6.1. Materials 
6.2. Evaluation of the methods  
6.3. Predictors of atrial fibrillation and its impact on outcome  
  
6.4. Logistic regression model 
6.5. Heart rate variability 
6.6. Atrial sizes 
6.7. Atrial peptides 
6.8. High-rate atrial pacing test 
7. SUMMARY AND CONCLUSIONS…………………………………79 
8. REFERENCES………………………………………………………...81 
 
 13 
1. INTRODUCTION 
   Atrial fibrillation (AF) is the most common arrhythmia in clinical practice. With the 
changing epidemiology of rheumatic disease, the most frequent underlying heart 
disease in AF is coronary heart disease (Kannel et al. 1982). The prevalence of AF 
increases with age, with a prevalence of less than 1% at age 50 but more than 9% at 
age 80 (Feinberg et al. 1995). 
 AF is most common arrhythmia after cardiac surgery. The patients undergoing 
valve surgery or combined valve and coronary artery bypass surgery (CABG) have 
higher incidence of postoperative AF than patients having CABG alone (Cresswell 
and Damiano 1993, Almassi et al. 1997). AF is especially common after mitral valve 
surgery, occurring in as many as 64% of patients (Asher et al. 1998). AF after CABG 
is self-limiting in most cases, but, even when it is uncomplicated, it requires 
additional medical treatment and a prolonged hospital stay, and it consequently 
increases the costs of operative treatment (Cresswell and Damiano 1993, Aranki et al. 
1996, Borzak et al. 1998). In some cases AF can cause hemodynamic compromise 
and increase the risk of stroke (Taylor et al. 1987, Creswell et al. 1993). 
 Prophylactic medical therapy decreases the incidence of postoperative AF after 
CABG. A meta-analysis of 24 randomised, controlled trials demonstrated that 
therapy with a b-adrenergic blocker decreases the incidence of AF after CABG by 
77% (Andrews et al. 1991). Prophylactic therapy with amiodarone has been shown to 
be effective in decreasing the incidence of AF after CABG (Daoud et al. 1997, 
Guarnieri et al. 1999). In addition to medical prevention, atrial pacing may play a 
significant role in the prevention of AF after CABG, especially when combined with 
medical therapy (Blommaert et al. 2000, Fan et al. 2000). 
 The most effective preventive methods, either medical prevention or preventive 
pacing strategy, require additional nursing and medical resources and expense. 
Prophylactic treatment to prevent AF with intravenous amiodarone is not cost-
effective if given to all patients (Mahoney et al. 2002). In addition, these treatments 
may have unfavourable side effects. Prophylaxis of the whole patient population 
 14 
undergoing GABG is not reasonable. Identification of patients who would be at high 
risk of AF after CABG would be very helpful. In this work we concentrated on 
methods to predict AF in post-CABG patients. 
 
2. REVIEW OF THE LITERATURE 
2.1. ATRIAL FIBRILLATION AFTER CABG 
2.1.1. PATHOPHYSIOLOGY 
   The pathophysiology of AF after cardiac operations is not fully understood. On the 
basis of experimental animal and clinical studies, underlying electrophysiological 
abnormality is a necessary substrate for AF. The pathophysiological mechanism is 
believed to be re-entry, which is facilitated when adjacent atrial regions have widely 
separated refractory periods. This non-uniform dispersion of refractoriness in the 
atrial tissue can set up local areas of functional blocks and the depolarising wavefront 
faces both refractory and excitable myocardium. This makes the re-entry 
phenomenon possible and can lead to AF (Cox et al. 1991, Cox 1993, Konings et al. 
1994). Prolonged atrial conduction may also favour re-entry, and serve as a substrate 
to AF (Cosio et al. 1983). It is speculated that this electrophysiological substrate is 
mandatory for the development of AF, which may explain why some patients get AF 
and some do not after the same surgical intervention (Cox 1993). The explanation is 
supported by the findings of histopathologic abnormalities such as myolysis and 
lipofuscin deposition in atrial tissue biopsies before cardiopulmonary bypass in 
patients who suffered postoperative AF (Ad et al. 2001) 
 In addition to an electrophysiological substrate, some triggering factor is 
required to begin the AF. In non-surgical patients this  triggering factor is a premature 
ectopic beat. The pulmonary veins are an important source of ectopic beats, initiating 
frequent paroxysms of AF (Haissaguerre et al. 1998, Jais et al. 2000). Atrial ectopic 
activity and tachyarrhythmias are more common just prior to the onset of AF after 
CABG compared to patients who remain in sinus rhythm. Premature atrial activity 
may thus serve as a triggering factor for AF (Frost et al. 1995a, Jideus et al. 2000). 
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Frost et al. also showed that AF could be initiated by atrial ectopic beats that first 
activate either the right or left atrium (Frost et al. 1995b). 
 Atrial ischaemia may also play a significant role in the development of 
underlying substrate and be a triggering factor of AF. Atrial tissue is warmer during 
cardioplegic arrest than ventricular tissue and electrical activity is often observed as a 
sign of inadequate atrial protection (Smith et al. 1983, Tchervenkov et al. 1983, Chen 
et al. 1988). There is a correlation between persistent electrical activity and 
postoperative atrial arrhythmias (Tchervenkov et al. 1983). Yet, augmented atrial 
hypothermia during cardioplegic arrest has no effect on the atrial effective refractory 
period or on the inducibility of AF in canine heart (Sato et al. 1992). There is strong 
association between arterial insufficiency to the sinoatrial or to the atrioventricular 
node and the incidence of post-CABG AF, which indicates that atrial ischaemia may 
play a role in the development of AF after CABG (Kolvekar et al. 1996). 
 It is believed that increased sympathetic nervous activity increases susceptibility 
to postoperative AF. Kalman et al. showed that the mean postoperative 
norepinephrine levels (reflecting sympathetic nervous activity) were significantly 
higher in patients who developed AF compared to patients who remained in sinus 
rhythm (Kalman et al. 1995). Hogue et al. studied autonomic balance before the onset 
of AF after CABG. Either high or low heart rate variability (HRV) was observed 
before AF. This indicates that in some patients high sympathetic tone is present 
before onset of AF but in others, either higher vagal tone or dysfunctional autonomic 
heart rate control is present before AF onset (Hogue et al. 1998). 
 Total and ionized serum magnesium concentrations are reduced by 
cardiopulmonary bypass (England et al. 1993). Decreased postoperative magnesium 
levels are associated with AF after cardiac surgery (Kalman et al. 1995, Zaman et al. 
1997). Jensen et al. found that during CABG the potassium levels fell and sodium 
increased in both right atrium and skeletal muscle, and on the second postoperative 
day the potassium content in skeletal muscle was not yet restored. Magnesium levels 
did not change in right atrium and skeletal muscle, but serum magnesium declined 
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postoperatively. They concluded that the observed electrolyte disturbances might be 
important in the development of the postoperative AF (Jensen et al. 1996). 
Magnesium is a cofactor of the myocardial cell membrane Na-K adenosine 
triphosphatase, which regulates transmembrane sodium and potassium gradients. 
Magnesium deficiency may predispose to arrhythmias by altering membrane 
potential and repolarisation via its effect on this enzyme (Fanning et al. 1991). 
 The reason for the delay from the operation to the onset of AF is not clearly 
known. After valve replacement significant pericardial effusion increases the risk of 
postoperative AF (Chidambaram et al. 1992). However, pericardial effusion and 
exaggerated inflammatory response are associated with postoperative arrhythmia 
(Bruins et al. 1997) and these factors may explain delay of the onset of AF. 
 
2.1.2. INCIDENCE 
   The reported incidence of AF after CABG varies widely depending on the 
particular definition used, the mode of postoperative monitoring of the patients, and 
the changing profile of the patients undergoing CABG. Table 1 presents atrial 
arrhythmia incidence after cardiac surgery, for those studies that included 300 
patients or more. The incidence of post-CABG AF varied between 17 and 33% in 
these studies. A meta-analysis of 24 trials (Andrews et al. 1991) the incidence of AF 
was estimated at 27%. Patients undergoing CABG and combined valve surgery have 
a higher incidence of postoperative AF than patients having CABG alone (Cresswell 
and Damiano 1993, Almassi et al. 1997). The peak of AF incidence occurred between 
the second and fourth days after the operation, with less than 10% on the first 
postoperative day (Aranki et al. 1996). 
 The frequency of AF after CABG is not decreasing. The incidence of AF in 
studies published recently is quite similar to those published a decade ago (Table 1). 
In series where surgeons, surgical methods and the methods of arrhythmia monitoring 
were deemed constant, Cresswell and Damiano found that the post-CABG incidence 
actually increased from 26% in 1986 to 36% in 1991(Cresswell and Damiano 1993). 
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 The incidence of AF after surgery on the beating heart is presented in the 
paragraph “Intraoperative predictors” (Section 2.1.3.2). 
 
2.1.3. CLINICAL PREDICTORS  
2.1.3.1. PREOPERATIVE PREDICTORS 
Old age predicts AF in the general population (Feinberg et al. 1995) and it is the most 
often reported independent risk factor for post-CABG AF (Table 1). The incidence of 
AF after cardiac surgery increases by at least 50% per ten years of increased age 
(Leic et al. 1990, Mathew et al. 1996, Almassi et al. 1997, Mahoney et al. 2002).  
Aging causes cardiac dilatation, myocardial atrophy, decrease of conduction tissue, 
and fibrosis in atria (Lie and Hammond 1988, Kitzman et al. 1990). These age-related 
changes may be responsible for increased risk for AF after CABG. 
 Preoperative history of AF is a factor which consistently associates with AF 
after CABG. Patients with a history of AF appear to have the underlying substrate 
necessary for the development of AF, and they are thus susceptible to postoperative 
AF (Mathew et al. 1996, Hashimoto et al. 1991, Svedjeholm and Håkanson 2000). 
The exclusion of patients with a history of AF is probably the reason why 
preoperative history of AF has not been found to predict postoperative AF in many 
studies. 
 Some authors have found preoperative use of digoxin as an independent risk 
factor for AF after cardiac surgery (Cresswell and Damiano 1996, Almassi et al. 
1997). It is apparent that digoxin has been used for heart failure and less 
compellingly, for prophylaxis of AF as well. The use of digoxin is often associated 
with sicker hearts. 
 Hypertension is a predictor of postoperative AF, and this may be related to 
increased fibrosis and to dispersion of atrial refractoriness (Aranki et al. 1996, 
Almassi et al. 1997, Svedjeholm and Håkanson 2000). But in many well-conducted 
studies involving large numbers of patients, hypertension has not been found to be an  
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Table 1. Atrial Fibrillation studies on after cardiac surgery showing the incidence of postoperative AF together with the 
suggested independent preoperative predictors of AF. Minimum of 300 patients. 
 
Study CABG 
patients, n  
Incidence of  
 AF, % 
Independent predictors of AF 
Fuller et al. 1989 473 28% Old age, male sex, absence of postoperative ß-blockers 
Leic et al. 1990 5807 17% Old age, COPD, chronic renal failure, preoperative ß-blockers 
Hashimoto et al. 1991 800 23% Old age, previous atrial arrhythmias, preop. atrial premature beats, preop. 
increased left ventricular pressure  
Cresswell et al. 1993 2833 32% Old age, male sex, preop. use of digoxin, COPD, PVD, smoking 
Matthew et al. 1996 2048 26% Old age, male sex, history of congestive heart failure, preop. heart rate >100 
Aranki et al. 1996 570 33% Old age, male sex, hypertension 
Almassi et al. 1997 3126 28% Increased age, COPD, preop. use of digoxin, hypertension, pulse rate <80 
Svedjeholm et al. 2000 775 29% Old age, hypertension, history of AF 
Zaman et al. 2000 326 28% Increased age, male sex, SAPD >155ms 
Mahoney et al. 2002 8709 18% Old age, male sex, previous MI 
Majahalme et al. 2002 586 32% Old age, use of radial artery grafts 
AF= Atrial fibrillation, COPD=Chronic obstructive pulmonary disease, MI= myocardial infarction,  
PVD=Peripheral vascular disease, SAPD= Signal averaged P-wave duration. 
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independent predictor of AF after CABG (Fuller et al. 1989, Hashimoto et al. 1991, 
Cresswell and Damiano 1993, Mahoney et al. 2002). 
   The blood supply to the right atrium, the sinoatrial node and the atrioventricular 
node is mainly conveyed via the right coronary artery. Pehkonen et al. found that 
patients with a total occlusion or severe stenosis of the proximal right artery had 
postoperative AF more often when retrograde cardioplegia was used (Pehkonen et al. 
1998). In other studies obstructive disease in the sinoatrial nodal and atrioventricular 
nodal arteries was more common in patients developing AF after CABG than in those 
who remained in sinus rhythm (Mendes et al. 1995, Kolvekar et al. 1996). Stenosis of 
the sinoatrial artery (Al-Shanafey et al. 2001) or the right coronary artery (De Jong 
and Morton 2000) have been found to be independent predictors of AF after CABG 
by other investigators. 
 Men appear more likely to develop AF after CABG than women. Sex 
differences in ion-channel expression and hormonal effects on autonomic tone may 
explain this difference between genders (Fuller et al. 1989, Aranki et al. 1996, 
Almassi et al. 1997, Zaman et al. 2000, Mahoney et al. 2002). However, there exist 
conflicting reports, in which male gender was not an independent predictor of AF 
(Hashimoto et al. 1991, Cresswell and Damiano 1993). 
 Chronic obstructive pulmonary disease (COPD) is a predictor of AF after 
cardiac surgery. COPD patients have frequent premature atrial contractions that act as 
a trigger for the initiation of AF (Leich et al. 1990, Cresswell and Damiano 1993, 
Almassi et al. 1997, Ad et al. 1999). 
 When long-term ß-blocking medication is abruptly discontinued, a phenomenon 
called ß-blocking withdrawal effect follows. It is characterised by increased 
catecholamine concentration in plasma. A withdrawal effect has been proposed as a 
possible cause of AF after cardiac operation when ß-blocking medication has been 
stopped at the time of surgery (White et al. 1984, Kalman et al. 1995). 
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 Several other factors have been found independently to predict the risk of AF 
after CABG: previous congestive heart failure (Mathew et al. 1996), previous 
myocardial infarction (Mahoney et al. 2002), resting pulse rate less than 80 (Almassi 
et al. 1997), precardiopulmonary heart rate over 100 (Mathew et al. 1996), peripheral 
vascular disease (Creswell and Damiano 1993), smoking (Cresswell and Damiano 
1993), three vessel coronary artery disease (Ducceschi et al. 1999), lower body mass 
index (Jideus et al. 2000), and left atrial enlargement (Ducceschi et al. 1999). 
 Long duration of P wave in signal-averaged electrocardiography (SAECG) as a 
predictor of AF will be discussed in paragraph “Signal average P-wave ECG” 
(Section 2.2.1.). 
 
2.1.3.2. INTRAOPERATIVE PREDICTORS 
   There are conflicting data about the association between aortic cross-clamp time 
and postoperative AF. Some (Caretta et al. 1991, Creswell and Damiano 1993, 
Mathew et al. 1996, Mahoney et al. 2002) studies show that long cross-clamp time 
increases the risk of postoperative AF, but in other studies the correlation was not 
found (Fuller et al. 1989, Hashimoto et al. 1991, Aranki et al. 1996). The type of 
cardioplegia does not seem to have effect on the incidence of postoperative AF 
(Butler 1993a, The warm heart investigators 1994, Pehkonen et al. 1995). Insulin-
enhanced blood cardioplegia does not decrease the incidence of postoperative AF 
when compared with standard blood cardioplegia (Hynynen et al. 2001). 
 A strong correlation was found between the duration of atrial activity during the 
cross-clamp time and the incidence of postoperative AF (Tchervenkov et al. 1983). In 
a recently published study the total volume of cardioplegia was significantly less in 
patients with AF compared with patients with sinus rhythm (Jideus et al. 2000). 
 During the last few years a growing number of coronary surgeries have been 
completed without using cardiopulmonary perfusion. From the theoretical standpoint, 
patients undergoing CABG without cardiopulmonary bypass (CPB) would not be 
subject to some precipitating factors of postoperative AF, i.e. atrial ischaemia, 
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cannulation trauma to the atrium, and CPB itself (Cresswell and Damiano 2001). 
There is conflicting information about the incidence of postoperative AF among 
patients after off-pump CABG. Table 2 presents studies comparing postoperative AF 
incidence after off-pump and conventional CABG. Unfortunately most of these 
studies are retrospective and involve only small number of patients. 
 Ascione et al. reported a randomised study of 200 patients, with a postoperative 
AF incidence of 49% after conventional CABG, compared with 14% after off-pump 
CABG. The incidence of AF after conventional CABG was very high but the use of 
ß-blocking medication was not reported (Ascione et al.  2000). Buffolo et al. reported 
a retrospective study involving 1,067 patients. They also found the incidence of atrial 
arrhythmias significantly lower after off-pump CABG compared with conventional 
CABG (Buffolo et al. 1996). Allen et al. reported no postoperative arrhythmias in a 
small group of patients who underwent single vessel redo off-pump CABG with the 
left anterior thoracic artery (Allen et al. 1997). Subramanian et al. reported their 
experience of minimally invasive direct coronary artery bypass grafting (MIDCABG) 
(Subramanian et al. 1997). They used minithoracotomy, subxiphoid and lateral 
thoracotomy incisions, and the incidence of AF was only 8% (14/185 patients). No 
difference in the frequency of postoperative AF was found in a small case-controlled 
study after MIDCABG and conventional CABG (Cohn et al. 1999). Similarly, no 
significant difference was found in a study comparing the incidences of AF after 
conventional CABG, MIDCABG and OPCABG (Siebert et al. 2000). In another 
study by Siebert et al, no difference was found between the incidence of AF after on-
pump and off-pump CABG during ICU stay (Siebert et al. 2001). There are also other 
negative studies, which did not reveal any difference in the incidence of AF after 
CABG with or without CPB (Saatvedt et al. 1999, Abrey et al. 1999, Mueller et al. 
2001). Tamis-Holland et al. compared 208 patients having MIDCABG or 
conventional CABG, and they concluded that the reason of low incidence of AF after 
MIDCABG is due to different clinical characteristics of patients compared to 
conventional CABG patients (Tamis-Holland et al. 2000). 
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Table 2. Studies comparing the incidences of postoperative AF after on-pump and 
off-pump CABG. 
 
STUDY Total number 
of patients 
Type of Study On pump 
AF, %  
Off pump 
AF, %  
P value 
Buffolo  1996 1067 Retrospective, 
OFFPUMP-ONPUMP 
12.6% 5.5% <0.05 
Allen 1997 35 Retrospective, only 
LIMA-LAD REDO 
58% 0% <0.05 
Cohn 1999 110 Case-control, 
MIDCAB-CABG 
20% 24% NS 
Saatvedt 1999 704 Retrospective 
ONPUMP-OFFPUMP 
36% 37% NS 
Ascione 1999 80 Prospective randomised 
ONPUMP-OFFPUMP 
38% 15% <0.05 
Abrey 1999 781 Retrospective, 
OFFPUMP-ONPUMP 
26% 12% 0.06 
Tamis -Holland 
2000 
209 Retrospective, 
MIDCAB-ONPUMP 
39% 23% <0.05 but NS 
in multivariate 
Ascione 2000 200 Prospective randomised 
ONPUMP-OFFPUMP 
49% 14% 0.001 
Siebert 2000 87 Retrospective 
ONPUMP-OFFPUMP 
27% 18% NS 
Mueller 2001 183 Retrospective, only 
LIMA-LAD  
18% 22% NS 
AF= Atrial fibrillation, CABG= Coronary artery bypass grafting,  
LAD= Left anterior descending artery, LIMA= Left anterior mammarian artery, 
MIDCABG=Minimally invasive direct coronary artery bypass grafting.  
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2.1.3.3. POSTOPERATIVE PREDICTORS 
   Postoperative pneumonia and mechanical ventilation longer than 24h have been 
shown to be independent postoperative predictors of AF (Aranki et al. 1996), as well 
as atrial pacing (Mathew et al. 1996), and need of postoperative inotropic agents 
(Almassi et al. 1997). Svedjeholm and Håkanson found that low postoperative mixed 
venous oxygen saturation and the need for postoperative mechanical circulatory 
support were independent predictors of post-CABG AF (Svedjeholm and Håkanson 
2000). In addition, a high central venous pressure at the time of admission to 
intensive care is predictive of a higher risk of AF (Frost and al. 1995c). 
 
2.1.4. IMPACT ON OUTCOME AND RESOURCE UTILIZATION 
   Most of the postoperative AF cases are temporary and the morbidity related to them 
is low. However, there is evidence that AF associates with adverse events, patient 
discomfort, the need for additional medication and treatment, decrease in cardiac 
output, hypotension, and congestive heart failure (Lamb et al. 1988, Creswell and 
Damiano 1993, Aranki et al. 1996, Paul et al. 1997). 
 The most serious complication of AF is stroke. Chung et al. found in their 
retrospective analysis of 8,389 CABG patients that postoperative AF independently 
increases the risk of embolic stroke 1.8 fold (Chung 1995). The same association has 
been found also in other studies (Taylor et al. 1987, Fuller et al. 1989, Creswell and 
Damiano 1993). 
 Increase in hospital stay relates to postoperative AF in many studies (Creswell 
and Damiano 1993, Lazar et al. 1995, Mathew et al. 1996, Aranki et al. 1996, Chung 
et al. 1996, Borzak et al. 1998, De Jong and Morton 2000). Aranki et al. noted that 
AF lengthens hospital stay by 4.9 days, which increased the costs of operation more 
than 10,000 USD. Mathew et al. noted that length of hospital stay increased from 
10.2 to 12.8 days with AF. The above-mentioned studies were based on patients who 
were operated between 1991 and 1994. 
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 A recently published study by Tamis et al. AF recorded a lengthening of the 
hospital stay after CABG by 3.2 days, and this effect was independent of other 
variables (Tamis et al. 2000). In another recently published study the impact of 
postoperative AF was found to be only 1 to 1.5 days (Kim et al. 2001). In a study by 
Hravnak et al. the new onset atrial fibrillation after CABG increased the total cost of 
treatment by more than 6,000 USD (Hravnak et al. 2002). The authors concluded that 
the economic impact of AF after CABG has been underestimated. 
 However, there is also a published study in which the postoperative AF did not 
affect the length of stay or costs (Gupta et al. 1996). 
 
2.1.5. TREATMENT 
   Spontaneous conversion of AF to sinus rhythm (SR) after cardiac surgery is 
common. 15% of patients convert to SR in two hours (VanderLugt et al. 1999) and 
80% in 24 hours (Cochrane et al. 1994) when either placebo or digoxin was given. 
 Two management strategies are available to treat AF after CABG: rate control 
and rhythm control. In addition, anticoagulant therapy must be remembered to reduce 
the risk of embolic complications (Ommen et al. 1997). There are no specific data on 
when anticoagulation therapy should be started on patients who have AF after 
CABG. Two reviews of postoperative AF recommend anticoagulant therapy with 
heparin and warfarin either if the AF persists for 24 hours (Ommen et al. 1997) or 
more than 48 hours (Maisel et al. 2001). 
 ß-blockers are considered first-line therapy for rate control when ventricular 
response is rapid (Andrews et al. 1991). Digoxin may slow down the ventricular 
response at rest, but seldom adequately when sympathetic tone is high. When ß-
blockers alone inadequately control the heart rate, calcium channel blockers may be 
administered to achieve adequate rate control (Maisel et al. 2001). Infusion of 
amiodarone can also be used for adequate rate control in AF (Cochrane et al. 1994). 
 Early electrical cardioversion may be necessary in hemodynamically 
compromised patients. Unfortunately, AF tends to relapse after cardioversion 
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(Ommen et al. 1997). Reports on the use of various antiarrhythmic drugs to restore 
SR in patients with AF after CABG show diverse results. This is partly due to 
spontaneous restoration of SR. Some of the drugs (dofetilide, procainamidi, 
intravenous quinidine) used in studies are not available in many countries, including 
Finland. 
 When antiarrhythmic therapy is indicated, drug-induced proarrhythmia should 
be avoided. Patients with a history of myocardial infarction, reduced ejection 
fraction, or high age are at particularly high risk for proarrhythmias (Friedman and 
Stevenson 1998). 
 The efficacy of flecainide, class IC antiarrhythmic agent for converting AF to 
SR after cardiac surgery has been shown (Cavaghan et al. 1988, Wafa et al. 1989). 
Since flecainide increases mortality after myocardial infarction, this drug should not 
be first choice for long-term oral therapy in patients with postoperative AF (Ommen 
et al. 1997). 
 Intravenous amiodarone therapy converts AF to SR within 12 to 24 hours in 
40% to 90% of patients, and amiodarone therapy provides effective rate control 
(McAlister et al. 1990, Cochrane et al. 1994). Another drug with class III 
antiarrhythmic properties, sotalol, leads to conversion to SR in 85% of patients in 12 
hours (Campbell et al. 1985). Ibutilide, a class III antiarrhythmic agent, given 
intavenously converted 44% of AF patients to SR after cardiac surgery compared of 
15% of patients who were given placebo, but ibutilide infusion was associated with 
an up to 3% risk of torsades de pointes proarrhythmia (Vander Lugt et al. 1999). 
 Overall, although many antiarrhythmic options are available to convert AF to 
SR after CABG, the combination of reasonable efficacy and low risk of 
proarrhythmia favours amiodarone as the drug of choice for patients requiring 
antiarrhythmic drug treatment (Ommen et al. 1997). 
 Less than 10% of patients with postoperative AF after CABG who are 
discharged in SR will have recurrent AF in six weeks after discharge, and 
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prophylactic treatment with calcium-channel blockers, quinidine, or amiodarone after 
discharge does not reduce to the rate of recurrence (Yilmaz et al. 1996). 
 
2.1.6. PREVENTION 
2.1.6.1. BETA-BLOCKING THERAPY 
   There are a large number of studies concerning the efficacy of ß-blockers in the 
prevention of AF after CABG. Three meta-analyses have confirmed the efficacy of ß-
blockers in AF prophylaxis (Andrews et al. 1991, Kowey et al. 1992, Crystal et al. 
2002). Meta-analyses published in 1991 and 1992 showed that the incidence of 
postoperative AF decreased from 34% and 20% to 8.7% and 9.8%, respectively. The 
ß-blocking agent used, the time of the initiation, or the dose administered did not 
influence the efficacy of the prophylactic therapy. In a recently published meta-
analysis (Chrystal et al. 2002) comprising 27 prospective randomised trials and 3,840 
patients, the incidence of AF decreased from 33% in the control group to 19% in the 
ß-blocking group. The ß-blocking agent used, the proportion of patients on ß-blocker 
preoperatively, study size, or the method of electrocardiographic monitoring did not 
influence the efficacy of the prophylactic therapy. 
 Yazicioglu et al. reported recently a prospective randomised study consisting of 
160 patients. The incidence of AF after CABG was only 5% in the group treated 
prophylactically with the combination of atenolol and digitalis compared with 
incidence of 15% to 25% in the groups treated with either of these medicines alone or 
placebo (Yaziciolglu et al. 2002). 
 Sotalol has been shown to decrease significantly the incidence of postoperative 
AF compared with placebo (Pfisterer et al. 1997, Weber et al. 1998, Gomes et al. 
1999). Three prospective randomised clinical trials have compared the efficacy 
between sotalol and other ß-blockers in the prevention of postoperative AF. Suttorp et 
al. compared low-dose sotalol (40 mg every 8 hours) and high-dose sotalol (80mg 
every 8 hours) to low- and high-dose propranolol (10 and 20 mg every 6 hours). They 
found a tendency of less supraventricular tachyarrhythmias in patients treated with 
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sotalol, and significantly fewer adverse effects were noted in both low-dose groups 
(Suttorp et al. 1990). Parikka et al. compared sotalol 120 mg daily to metoprolol 75 
mg daily postoperatively in 191 concecutive CABG patients (Parikka et al. 1998). AF 
occurred in 16% of sotalol patients and 32% of metoprolol patients (p<0.01). 
Proarrhythmic adverse effects did not appear. In another study comparing sotalol to 
metoprolol the incidence of supraventricular tachyarrhythmias were 2.4% and 15.3%, 
respectively (Janssen et al. 1986).  Although previously mentioned papers showed 
that sotalol is more effective than other ß-blockers in prevention of postoperative AF 
there is a concern over its potential to create proarrhythmic side effects. In a review 
of non-surgical patients the proarrhythmic risk associated with sotalol has been 
reported to be from 4.3% to 5.9% in patients receiving sotalol after myocardial 
infarction (Soyka et al. 1990). 
 In a pilot study by Balcetyte-Harris et al. intravenous esmolol was compared to 
oral ß-blocker therapy in prevention of AF after CABG (Balcetyte-Harris et al. 2002). 
They found intravenous esmolol less tolerated and the drug did not offer any 
advantages to standard ß-blocker therapy. 
 In conclusion, the routine early postoperative administration of ß-blockers is 
considered standard therapy to reduce the risk of AF after CABG (Eagle et al. 1999). 
 
2.1.6.2. AMIODARONE THERAPY 
   The feasibility of amiodarone for prevention of AF after cardiac surgery has been 
interesting. Daoud et al. reported that amiodarone lowered the incidence of atrial 
fibrillation after bypass and valve surgery by 53% (Daoud et al. 1997). They started 
oral amiodarone therapy (600 mg per day for seven days, then 200 mg per day) for a 
minimum of seven days before elective cardiac surgery and continued it until the day 
of discharge from the hospital. Two individual oral amiodarone regimens were 
compared in a double-blind prospective trial (White et al. 2002). When amiodarone 
therapy (7 g oral amiodarone in ten days) was started five days before cardiac surgery 
it reduced significantly the incidence of AF, of symptomatic AF, and of AF lasting 
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more than 24 hours. If the therapy (6 g oral amiodarone in six days) was started one 
day before surgery it reduced the risk of symptomatic AF, of AF lasting more than 24 
hours, and showed a trend for prevention of any AF. Giri et al. randomised 220 
patients, older than 60 years, to receive either oral amiodarone or placebo starting 1 
(6 g amiodarone over six days) or 5 days (7 g amiodarone over ten days) before 
surgery. Concomitant ß-blocking therapy was given to 90% of the patients. Both 
regimens were effective in the prevention of AF. The incidence of AF in the 
amiodarone group was 22.5% compared to 38% in the placebo group (p=0.01). There 
was also significant difference in favour of amiodarone in the preventing of 
cerebrovascular accidents and postoperative ventricular tachycardia. 
 Several studies have focused on the feasibility of intravenous amiodarone for 
prevention of postoperative AF after CABG (Hohnloser et al. 1991, Butler et al. 
1993b, Guarnieri et al. 1999, Lee et al. 2000). Hohnloser et al. reported a significant 
reduction in the incidence of AF when amiodarone, compared with placebo, was 
given for two days postoperatively (5% vs. 21%, respectively). Overall the incidence 
of AF was low in this study. Guarnieri et al. also gave intravenous amiodarone or 
placebo for two postoperative days with a significant reduction of AF (35% vs. 47% 
respectively). The incidence of AF was high in the placebo group, which may have 
been related to a high ß-blocker withdrawal rate. Butler et al. gave a 24-hour 
intravenous amiodarone infusion (15 mg/kg) after operation and oral amiodarone 
(600 mg daily) therapy for five days. The overall incidence of supraventricular 
tachyarrhythmias did not differ between amiodarone and placebo groups but the 
arrhythmias requiring therapy were reduced in amiodarone group. More bradycardia 
occurred in amiodarone treated patients. Lee et al. started intravenous amiodarone 
therapy three days before CABG and continued it for five days after surgery. They 
found a significant reduction in the incidence of AF (12% vs. 34%), ventricular rate 
during AF, and the duration of AF, compared to placebo group. 
 Conflicting results in the efficacy of amiodarone for preventing postoperative 
AF have been found by Dörge et al. 2000 and Redle et al. 1999. Dörge et al. 
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randomised 150 patients to receive intravenous amiodarone (two regimens) or 
placebo during three days after CABG. There was no difference in the incidence of 
AF between the groups. Redle et al. used a 1-4 day (2g) preoperative loading and 
continued with 400 mg amiodarone daily for 7 days postoperatively in CABG 
patients. They achieved a non-significant 25% reduction in AF incidence. Treggiari-
Venzi et al. gave intravenous amiodarone (900 mg per 24 h) for 72 hours in a double-
blind controlled study. The reduction of AF incidence was not significant (14% vs. 
27%) in the amiodarone group, but the administration of amiodarone was associated 
with a longer duration of cardiovascular instability, and an extended need for 
intensive care (Treggiari-Venzi et al. 2000). 
 In a meta-analysis of prospective randomised trials comprising 9 studies and 
1,384 patients, amiodarone reduced the percentage of patients with AF from 37% in 
the control group to 22.5% in the amiodarone group (Crystal et al. 2002). 
 Mahoney et al. assessed the cost-effectiveness of intravenous amiodarone 
therapy (Mahoney et al. 2002). They found routine use of intravenous amiodarone 
after CABG not to be cost-effective. Older patients undergoing valve surgery with 
concomitant CABG, or who had had COPD, were likely to benefit most from 
intravenous amiodarone therapy. 
 In conclusion, routine amiodarone administration to all patients for reduction AF 
after CABG cannot be recommended. Instead, amiodarone should be given to 
patients at high risk for AF after CABG. 
 
2.1.6.3. MAGNESIUM SUBSTITUTION 
   Hypomagnesemia is a common feature after CPB (Fanning et al. 1991, England et 
al. 1992). Low serum magnesium level is an independent predictor for AF after 
CABG (Zaman et al. 1997, Treggiari-Venzi et al. 2000), even though the serum 
magnesium concentration does not correlate with intracellular and myocardial 
magnesium (Reinhart et al. 1991). 
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 Majority of the studies have shown that prophylactic administration of 
magnesium reduces the incidence of atrial arrhythmia after cardiac surgery (Fanning 
et al. 1991, Colquhoun et al. 1993, Wistbacka et al. 1995, Toraman et al. 2001, 
Wilkes et al. 2002). Fanning et al. randomised 99 patients to receive either 178 mEq 
of magnesium or placebo over the first four postoperative days. Significantly fewer 
episodes of AF occurred in the group receiving supplemental magnesium. Wistbacka 
et al. compared high dose (4.2g before CPB followed by an infusion of 11.9 g until 
first morning and a further 5.5g until second postoperative morning) and low dose 
(2.9 g at the first postoperative morning and 1.4 g at the second postoperative 
morning) magnesium supplementation in prevention of AF after CABG. A significant 
reduction of AF incidence was found in the high dose group compared to the low 
dose group (7.3% vs. 25%, respectively). It is remarkable that also the patients in the 
low dose group were normomagnesemic postoperatively. Toraman et al. randomised 
200 CABG patients to receive either 6 mmol magnesium on the day before surgery, 
just after CPB and once a day for four days postoperatively or placebo. The incidence 
of AF in the magnesium group was astonishingly low, only 2%, on the contrary, in 
the placebo group, it was 21% (p<0.0001). In a study by Jensen et al. the magnesium 
substitution reduced the duration of atrial fibrillation or flutter but not the number of 
patients developing these arrhythmias (Jensen et al. 1997). 
 On the contrary there are studies, which have shown that prophylactic 
administration of magnesium does not decrease the incidence of AF after CABG. 
Parikka et al. showed that administration of 70 mmol of magnesium in the first 48 
hours after cardiac surgery did not decrease the incidence of postoperative AF 
(Parikka et al. 1993). They reported that high plasma magnesium concentration 
perioperatively led to a higher incidence of AF. In that study the patients in the 
magnesium group were significantly older, had more prior episodes of AF, and used 
digoxin more often before the surgery. Karmy-Jones et al. showed that administration 
of 14.4 g of magnesium in the first 24 hours after the cardiac operation did not reduce 
the incidence of supraventricular tachyarrhythmias (Karmy-Jones et al. 1995). 
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 One retrospective study compared the effectiveness of magnesium 
supplementation in preventing atrial tachyarrhythmias in patients undergoing off-
pump CABG (Maslow et al. 2000). The incidence of postoperative atrial arrhythmias 
was significantly lower in magnesium group compared to control group (12% vs. 
29%, respectively).   
   The role of magnesium in the prevention of AF after CABG remains unclear. 
 
2.1.6.4 OTHER MEDICAL THERAPY 
   Digoxin administered prophylactically does not reduce the incidence of AF after 
CABG (Tyras et al. 1979, Andrews et al. 1991, Kowey et al. 1992). Prophylactic use 
of verapamil was not shown to be different from controls in reducing the likelihood 
of AF after CABG according to a meta-analysis (Andrews et al. 1991). 
 Intravenous postoperative administration of diltiazem reduced significantly the 
risk of postoperative AF after CABG compared with intravenous nitroglycerin 
administration in four studies (Hannes et al. 1993, Seitelberger et al. 1994, el-Sadel 
and Krause 1994, Malhotra et al. 1997), without evidence of haemodynamic 
compromise. No placebo-controlled trials have evaluated diltiazem for prevention of 
AF after CABG. 
 The effect of perioperative triiodothyronine supplementation was studied in one 
prospective double-blind study involving 142 CABG patients with depressed left 
ventricular ejection fraction (Klemperer et al. 1996). Triiodothyronine-treated 
patients had statistically significant lower incidence of AF postoperatively (24% 
versus 46%). 
 In a meta-analysis of 52 randomised trials various prophylactic therapies against 
postoperative AF after cardiac surgery were analysed. ß-blockers, sotalol and 
amiodarone all reduced the risk of postoperative AF with no marked difference 
between them (Crystal et al. 2002). 
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2.1.6.5. PREVENTION BY ATRIAL PACING 
   Few studies have investigated the role of atrial pacing for the prevention of AF after 
cardiac surgery. Table 3 summarises the controlled trials of atrial pacing for the 
prevention of AF. Gerstenfeld et al. found continuous right or biatrial pacing in the 
postoperative setting safe and well tolerated (Gerstenfeld et al. 1999). Although the 
incidence of AF episodes in the paced groups was the same as that in the control 
group, the authors noted that the combination of ß-blocking medication and 
preventive pacing significantly reduced the incidence of AF. In another study 
Gerstenberg et al. found that biatrial pacing together with ß-blocking therapy after 
CABG reduces the incidence of postoperative AF. Particularly patients over 70 years 
appeared to benefit most of this combination therapy (Gerstenfeld et al. 2001). 
Greenberg et al. randomised 154 patient to four groups: one control group and three 
groups treated with permanent atrial overpacing with different pacing sites 
(Greenberg et al. 2000). The proportion of documented AF episodes was only 17% in 
the paced groups versus 37% in the control group. Blommaert et al. tested the 
effectiveness of right atrial pacing with continuous atrial dynamic overdrive pacing to 
ensure effective atrial capture in >90% of heart cycles (Blommaert et al. 2000). The 
incidence of documented AF episodes was significantly lower in the paced group 
(10%) compared to control group (27%). In Fan et al’s study biatrial pacing proved 
significantly more effective than single site right atrial or single site left atrial pacing 
(Fan et al. 2000). In another study, biatrial pacing was compared with no pacing at 
all, and a marked decrease in the incidence of AF was reported in the paced group 
(Levy et al. 2000). In a double-blind, randomised study 118 patients who underwent 
open heart surgery were assigned to right atrial pacing at 45 bpm (AAI), right atrial 
triggered pacing at a rate of >85bpm and biatrial pacing at a rate of >85bpm. The 
incidences of postoperative AF were 28%, 32% and 10%, respectively. There was a 
statistically significant difference indicating benefit to the biatrial paced group 
(Daoud et al. 2000). 
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Table 3. Controlled studies of atrial pacing for the prevention of AF after cardiac 
surgery. 
 
STUDY N PACING MODE PACING SITE CONCLUSION OF 
THE STUDY 
Kurtz et al. 1999 21 10 bpm over native HR BAP Study was stopped due 
to proarrhythmic 
effect of BAP 
 
Gerstenfelt et al. 1999 61 100 bpm RAP, BAP No difference between 
groups in AF 
incidence 
 
Daoud et al. 2000 118 85 bpm or 10 bpm over 
native HR 
RAP, BAP Significant reduction 
of AF in BAP group 
 
Levy et al. 2000 130 80 bpm BAP Significant reduction 
of AF in paced group 
 
Fan et al.  2000 132 90 bpm or 10 bpm over 
native HR 
LAP, RAP, BAP AF decreased in study 
groups; BAP was the 
most effective 
 
Blommaert et al. 2000 69 Dynamic atrial Overdrive 
pacing 
RAP Significant reduction 
of AF in paced group 
 
Greenberg et al. 2000 154 100-110 bp m LAP, RAP, BAP AF decreased in study 
groups; RAP was the 
most effective 
 
Chung et al. 2000 100 10 bpm over native HR Not mentioned No difference between 
groups in AF 
incidence 
Gerstenfelt et al. 2001 118 100 BAP Trend toward 
reduction of AF in 
paced group 
 
Abbreviations: BAP = biatrial pacing, BPM = beats per minute, HR = heart rate,  
LAP = left atrial pacing, RAP = right atrial pacing 
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 There are also two studies, which have shown that atrial pacing does not 
decrease incidence of AF after CABG. 100 patients were randomised to AAI pacing 
at 10 beats/min or more above the resting heart rate and to control group with no 
pacing (Chung et al. 2000). There was no difference in the incidence of AF between 
the study groups and, paradoxically, atrial ectopy was more frequent in the paced 
group. Kurz et al. compared medical therapy with biatrial pacing via epicardial wires 
for prevention of postoperative AF in a prospective randomised study. After 21 of the 
planned 200 patients, the study was prematurely aborted because of the 
proarrhythmic effect of biatrial pacing; 6 of the 12 patients treated with biatrial 
pacing developed sensing failure, which provoked AF in 5 of these 6 patients (Kurz 
et al. 1999). 
   In conclusion, temporary atrial pacing may play a significant role in the prevention 
of AF after cardiac surgery. Further studies are needed to confirm the feasibility of 
atrial pacing in the prevention of postoperative AF and to find the most effective 
pacing algorithms and pacing sites.  
 
2.1.6.6. POSTERIOR PERICARDIOTOMY 
   Posterior pericardiotomy was firstly reported by Mulay et al. to reduce the 
incidence of AF after CABG (Mulay et al. 1995). Echocardiographically observed 
pericardial effusion decreased from 40% in a control group to 8% in the 
pericardiotomy group, with a reduction in the incidence of supraventricular 
tachyarrhythmias from 36% to 8%. The effect of pericardiotomy on the incidence of 
AF after CABG was confirmed in another randomised prospective study of 150 
patients. A 4 centimeter longitudinal incision of posterior pericardium reduced the 
incidence of postoperative AF from 32% in the control group to 9% in the 
pericardiotomy group (Farsak et al. 2001). Also Kuralye et al. confirmed the efficacy 
of posterior pericardiotomy in prevention of AF after CABG in a prospective 
randomised study (Kuraley et al. 1999). 
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 In contrast, a prospective, controlled trial involving 100 patients by 
Asimakopoulos et al., posterior pericardiotomy had no effect on the incidence of AF 
after CABG (Asimakopoulos et al. 1997). 
 
2.2. CURRENT METHODS FOR PREDICTING THE RISK OF ATRIAL 
FIBRILLATION AFTER CABG 
2.2.1. SIGNAL AVERAGE P-WAVE ECG 
   Recent studies have demonstrated that signal-averaged P-wave ECG analysis is 
useful in identifying patients at high risk for developing AF after cardiac surgery. 
Specifically, abnormal atrial conduction, defined by a prolonged filtered P-wave 
duration in signal-averaged P-wave ECG analysis, has been shown to be an 
independent predictor of postoperative AF (Steinberg et al. 1993, Klein et al. 1995, 
Zaman et al. 1997, Stafford et al. 1997, Aytemir et al. 1999, Caravelli et al. 2002). 
Table 4. summarises the studies of signal-averaged P-wave ECG analysis in 
predicting the risk of AF after cardiac surgery. 
   In these studies the abnormal P-wave duration varied from 122 ms to 155 ms. 
Sensitivity of signal-averaged P-wave duration in identifying the patients who 
developed AF postoperatively was 68%-86%, and specificity was 39%-88%. The 
positive predictive value and negative predictive value varied from 34% to 76% and 
from 83 to 85%, respectively. 
 The predictive value of the signal-averaged P-wave duration is further enhanced 
when it is combined with ejection fraction. When P-wave duration was>140ms and 
ejection fraction<40% the risk for postoperative AF was nearly nine times higher 
compared to the situation when both were normal (Hutchinson and Steinberg 1996). 
 Similarly, the combination of P-wave duration (>155 ms) and low serum 
magnesium concentration (<0.7mmol) on the first postoperative day increased the 
positive predictive value from 37% to 62% (Zaman et al. 1997). 
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 When P-wave duration (>122.3 ms) and the presence of right coronary artery 
lesion were combined, the positive and negative predictive values were subsequently 
81% and 76% (Aytemir et al. 1999).   
 
 
 
Table 4. Comparison of signal-averaging P wave studies for predicting the risk of AF 
after cardiac surgery. 
 
STUDY N P-DURATION SPECIFICITY SENSITIVITY 
Steinberg et al 1993 
 
130 140 ms 55% 77% 
Klein et al 1995 
 
45 155 ms 79% 69% 
Hutchinson and 
Steinberg 1996 
 
272 140 ms 39% 82% 
Zaman et al 1997 
 
102 155 ms 45% 86% 
Stafford et al 1997 
 
201 141 ms 48% 73% 
Aytemir et al 1999 
 
53 122 ms 88% 68% 
Caravelli et al 2002 
 
129 135 ms 73% 84% 
N=Number of the patients studied, ms=milliseconds, P-duration= Cut off value of P-wave duration 
used in the study 
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2.2.2.   STANDARD ELECTROCARDIOGRAPHY 
   There are conflicting data concerning the standard ECG as a tool for predicting the 
risk of AF after cardiac surgery. Buxton and Josephson first reported that patients 
developing AF after CABG had a significantly longer P-wave duration in the 
standard ECG (Buxton and Josephson 1981). In a recently published study (Chang et 
al. 1999) the presence of prolonged P-wave duration (>100ms in lead II) was an 
independent predictor of AF with 1.9-fold risk compared to a P-wave duration less 
than 100 ms. The P-wave duration in both the signal averaged ECG and in the surface 
ECG were prolonged in patients who had AF after CABG (Dimmer et al. 1998). In 
the latter study a significant correlation was found between the P-wave duration in 
standard ECG and signal-averaged ECG. In a study published by Aytemir et al. lead 
II P-wave duration and left atrial enlargement in the electrocardiograph were 
determined from standard ECG. In multivariate analysis left atrial enlargement 
(relative risk 2.7 fold) but not the P-wave duration was an independent predictor of 
AF after CABG (Aytemir et al. 1999). Passman et al. found that P-wave duration in 
lead V1 was an independent predictor of AF after CABG (Passman et al. 2001). The 
age-adjusted odds ration (OR) for AF was 2.30 when P-wave duration in lead V1 was 
>110 milliseconds. Tsikouris et al. measured P-wave dispersion and maximum P-
wave duration on the 12-lead ECG preoperatively and on postoperative day 1-4 in 
patients undergoing open-heart surgery (Tsikouris et al. 2001). They found that P-
wave dispersion is greatest on days 2 and 3 and the longest atrial conduction time is 
greatest on day 3 after open-heart surgery, findings that coincide with the time of 
greatest risk of AF. 
 Steinberg et al. did not find a statistically significant difference of long P-wave 
duration in the standard ECG between patients who progressed to AF and those who 
remained in SR after CABG. Stafford et al. analysed lead II P-wave duration, total  P-
wave duration, and P-terminal force in standard ECG. No significant differences were 
observed in any of these variables between patients who developed AF and who did
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not after CABG (Stafford et al. 1997). Similarly, no difference was reported on  P-
wave duration on standard ECG between the patients with AF and without AF after 
CABG in recently published study (Caravelli et al. 2002). 
 
2.2.3.    ECHOCARDIOGRAPHY 
   Two papers have shown left atrial enlargement to predict AF after open-heart 
surgery (Ducceschi et al. 1999, Giri et al. 2001). In a study by Ducceschi et al. the 
left atrial enlargement in transthoracic echocardiography was the strongest predictor 
of postoperative AF in CABG patients. The same finding was determined by Giri et 
al. in patients undergoing CABG, valve surgery or both. Asher et al. found left atrial 
enlargement to be an independent predictor of AF early after cardiac valvular surgery 
(Asher et al. 1998). 
 There are also contrary findings. In two studies the left atrial enlargement was 
not found to be independent predictor of AF after CABG (Stafford et al. 1997, Jideus 
et al. 2000). In addition, the study by Zaman et al. did not reveal any difference in the 
size of left atrium in echo assessment between the patients who had AF and those 
who remained in SR, but their study included only 64 patients and was subgroup of a 
larger study population (Zaman et al. 2000). 
 
 
2.3.       HEART RATE VARIABILITY 
2.3.1. HEART RATE VARIABILITY AS PROGNOSTIC PREDICTOR IN 
CORONARY HEART DISEASE 
   The clinical implications of HRV analysis have been recognised in only two 
clinical conditions: as a predictor of risk of arrhythmic events or sudden cardiac death 
after acute myocardial infarction, and as a clinical marker of evolving diabetic 
neuropathy (Stys and Stys 1998). 
 In a multicentre postinfarction study involving 1,284 patients a strong 
correlation has been found between reduced HRV and total post-infarction mortality. 
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The observedly reduced HRV was independent of other prognostic factors and the 
prognostic value was further enhanced in the subgroup of patients with a left 
ventricular ejection fraction of less than 30% (La Rovere et al. 1998). In an 
observational follow-up study involving 715 patients with recent myocardial 
infarction, reduced HRV was associated with a 2-3 fold relative increased risk for 
sudden cardiac death (Bigger et al. 1992). In an observational follow-up study by 
Hartikainen et al., sudden arrhythmic death was associated predominantly with 
depressed HRV and ventricular tachycardia runs (Hartikainen et al. 1996). In a 
recently published observational follow-up study analysis of the fractal characteristics 
of short term R-R interval dynamics was found to give more powerful prognostic 
information than traditional measures of HRV among patients with depressed 
ejection fraction after acute myocardial infarction (Huikuri et al. 2000). 
 In a case controlled study, 22 survivors of out-of hospital cardiac arrest, which 
was not associated with acute myocardial infarction, were compared with 22 control 
patients matched with respect to age, sex, previous infarctions, ejection fraction and 
the severity of coronary artery disease. HRV parameters were reduced in cardiac 
arrest patients compared to controls (Huikuri et al. 1992). 
 Pozzati et al. analysed eight patients who succumbed to ischaemic sudden death 
during ambulatory ECG monitoring. They found a marked decrease in HRV 
immediately before the onset of the ST-shift, which precipitated the ischaemic 
sudden death (Pozzati et al. 1996). The records of implanted cardioverter-
defibrillators were analysed in 58 patients (Pruvot et al. 2000). A state of sympatho-
excitation was suggested by significant reduction in HRV before the ventricular 
tachyarrhythmias. 
 The specificity and predictive accuracy of altered HRV in predicting fatal 
arrhythmic events is relatively low. Therefore, widespread clinical application of this 
method has not been established for monitoring the heart-rate behaviour in individual 
patients (Lombardi et al. 2001). 
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   Vikman et al. measured traditional time and frequency domain HRV indices, along 
with the short-term scaling exponent a and approximate entropy before the episodes 
of AF in 22 patients without structural heart disease (Vikman et al. 1999). Traditional 
HRV measures showed no significant changes before the onset of AF. But they 
observed that a decrease in the complexity of R-R intervals and altered fractal 
properties in shot-term R-R interval dynamics prededed the spontaneus onset of AF. 
 
2.3.2. HEART RATE VARIABILITY AS PREDICTOR OF ATRIAL 
FIBRILLATION IN THE RECOVERY PHASE AFTER CABG 
   Two studies have evaluated HRV preceding onset of AF after CABG with 
somewhat divergent results. Dimmer et al. analysed the HRV preceding onset of AF 
after CABG. They found that the LF/HF ratio was initially significantly lower in the 
AF group compared to the SR group, and there followed a significant increase in 
LF/HF ratio compared with the initial values in the AF patients (Dimmer et al. 1998). 
They concluded that a shift in the autonomic balance, with a loss of vagal tone and a 
moderate increase in sympathetic tone, are observed before the onset of AF. Also, 
Hogue et al. performed HRV analysis before the onset of AF in patients after CABG. 
They observed either lower or higher measures of HRV before AF, a finding 
consistent with a divergent autonomic condition before AF onset. They thought that 
in some patients heightened sympathetic tone is present before AF, but, in others, 
either higher vagal tone or dysfunctional autonomic heart rate control is present 
before AF onset (Hogue et al. 1998). 
 
2.4. ATRIAL PEPTIDES 
2.4.1. CLINICAL IMPORTANCE OF ATRIAL PEPTIDES 
   Atrial natriuretic peptide (ANP) is produced primarily in the cardiac atria. Increased 
atrial wall tension, reflecting increased intravascular volume, is the dominant 
stimulus for its release. ANP is synthesised from prohormonen. Endocrinological 
active peptide ANP and its N-terminal prohormone fragments (N-ANP) are found in 
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plasma. Brain natriuretic peptide (BNP) is synthesised from prohormones mainly in 
cardiac ventricles (Levin et al. 1998). 
 It is well established that circulating ANP levels are increased in patients with 
chronic congestive heart failure in proportion to the severity of the disease and are 
elevated in patients with asymptomatic left ventricle dysfunction. Also the prognostic 
implications of ANP have been established in heart failure patients (Bonow 1996). 
 During the subacute phase of myocardial infarction, the cardiac natriuretic 
peptides are well-documented markers for identifying heart failure and they are 
powerful predictors of morbidity and mortality (Mair et al. 2001). 
 Natriuretic peptides have an excellent negative predictive value, particularly in 
high-risk patients. An increase in BNP is serious enough to warrant follow-up 
examinations. The measurement of natriuretic peptides can be used for quid therapy 
in heart failure and for risk stratification in heart failure and myocardial infarction 
(Mair et al. 2001). 
 In 911 healthy subjects high BNP and N-ANP were associated with old age, 
female gender, low diastolic blood pressure, low BMI, and high left atrial size (Wang 
et al. 2002). 
 
2.4.2. ATRIAL PEPTIDES AND ATRIAL FIBRILLATION 
    It has been shown that AF is an independent determinant of high N-ANP levels, 
but, conversely high BNP levels are not uniquely associated with AF (Rossi et al. 
2000). Longstanding AF causes depletion of ANP and N-ANP in patients with 
congestive heart failure. This finding suggests that longstanding AF leads to impaired 
ability of atria to produce these hormones because of the inherent degenerative 
processes (van der Berg et al. 2001). 
 ANP or N-ANP levels are not predictors of conversion to SR in AF patients 
(Hornestam et al. 1998, Shotan et al. 2001). Instead, elevated ANP level is an 
independent predictor of AF paroxysms in chronic heart failure. ANP levels higher 
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than 60 pg/ml had a hazard ratio of 8.6 for AF in 75 patients who had congestive 
heart failure but no previous AF (Yamada et al. 2000). 
 
2.4.3.       ATRIAL PEPTIDES AND CARDIOPULMONARY BYPASS 
   The concentration of ANP decreases during aortic cross-clamping, and a rebound 
increase occurs after removal of the clamp (Northridge et al. 1992). It has been 
shown that CPB decreases the molar ratio of cyclic guanosine monophosphate to 
ANP, which may represent the ANP biological activity (Hayashida et al. 2000). 
Kaukinen et al. showed that in patients with occluded right coronary artery both ANP 
and N-ANP concentrations were higher, and right ventricle ejection fraction was 
lower than in the patients with patent righ coronary artery during the postoperative 
course after CABG (Kaukinen et al. 1997). They concluded that ventricular 
expression of ANP may be stimulated by right ventricular distension. 
 Human ANP was given for 24 hours from the start of CPB (Sezai et al. 2000). 
The patients who received human ANP showed significantly higher glomerular 
filtration rates, lower levels of renin, angiotensin-II, aldosterone, and pleural effusion 
and larger urine volume, compared with control patients. The authors concluded that 
the administration of human ANP compensated for the shortcomings of CPB by 
decreasing the peripheral vascular resistance, by suppressing the renin-angiotensin-
aldosterone system, and by exerting a strong diuretic effect. 
 
 
2.5.  INTRAOPERATIVE SCREENING TEST 
   Intraoperative testing to determine the local refractory period of a particular site in 
the atrium is not technically feasible (Cox 1993). The value of intraoperative 
induction of AF has been studied in 50 patients who underwent CABG (Lowe et al. 
1991). The intraoperative induction of atrial fibrillation with alternating current had a 
sensitivity of 94% and a specificity of 41% for the occurrence of postoperative atrial 
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arrhythmias. The negative and positive predictive values of the test were 0.93 and 
0.47, respectively. 
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3. AIMS OF THE PRESENT STUDY 
The aim of this study was to evaluate if patients at high risk of developing AF after 
CABG can be identified preoperatively or intraoperatively. 
 
The specific aims were: 
 
1. To determine the risk factors of postoperative AF in a large group of patients 
undergoing CABG and to create predictive model of postoperative AF after 
CABG. A secondary aim of this study was to evaluate the effects of AF on 
patients’ outcome (I).  
 
2. To measure HRV preoperatively in CABG patients in order to test the 
hypothesis that increased sympathetic tone before surgery predicts AF after 
CABG (II).  
 
3. To test the hypothesis that increased atrial sizes and increased level of atrial 
peptides would be predictors for AF after CABG. Secondarily we measured atrial 
peptides in the early postoperative period (III). 
 
4. To test whether AF induced by intra-operative atrial high-rate pacing can be 
used to identify patients at risk for postoperative AF (IV). 
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4. PATIENTS AND  METHODS 
4.1 .          PATIENTS 
4.1.1.       STUDY I 
   The study was conducted at Kuopio University Hospital, having been approved by 
the Ethical Committee. The need for informed consent was waived, because the data 
used for the study had already been collected for clinical purposes. The retrospective 
material consisted of 3,676 patients having undergone CABG requiring 
cardiopulmonary bypass between January 1, 1992 and December 31, 1996. Patients 
who had AF in the preoperative ECG or some accompanying procedures in addition 
to CABG were excluded. The preoperative, perioperative and postoperative data were 
collected from the patient records and stored in the cardiac surgical database. The 
association of pre- and perioperative factors to postoperative AF were assessed, as 
were the occurrence and consequences of postoperative complications being 
associated with development of AF. 
 The regression model predicting postoperative AF was tested in the 
prospectively collected material. The prospective material consisted of 1,107 CABG 
patients operated between September 1, 1998, and December 30, 1999. The exclusion 
criteria were the same as in the retrospective material. Detailed pre-, peri- and 
postoperative data were collected by a cardiologist and were entered into a cardiac 
surgical database. There were no apparent differences in operative techniques or 
postoperative protocols between the retrospective and prospective patient series. 
 
4.1.2. STUDY II AND STUDY III 
   The patient population was the same in study II and study III. One hundred patients 
were randomly enrolled into the study between November 1999 and November 2000 
providing they fulfilled the inclusion criteria: elective primary isolated CABG using 
cardiopulmonary bypass. The exclusion criteria were: previous AF episodes, acute 
myocardial infarction within a month before surgery and ejection fraction less than 
50% measured with echocardiography or left ventricle kine-angiogram. All 
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procedures used in this study were approved by the Kuopio University Ethical 
committee. Informed consent was obtained from every patient before entering the 
study. 
 
4.1.3. STUDY IV 
   Eighty patients scheduled for elective cardiopulmonary bypass requiring CABG in 
Kuopio University Hospital between August 2000 and June 2001 were included in 
the study. Patients with a history of AF were excluded. Also patients with additional 
procedures or with unstable angina pectoris were not included. The study protocol 
was approved by the Kuopio University Ethical committee. Informed consent was 
obtained from every patient before entering the study. 
 
4.2. DESCRIPTION OF PROCEDURES 
4.2.1. OPERATIVE TECHNIQUE 
   The ascending aorta was cannulated for arterial line and a single stage venous 
cannula was inserted through the auricle of the right atrium. Aortic root venting was 
used routinely. Cardiopulmonary bypass with moderate systemic hypothermia 
(temperature of venous blood 32oC) and moderate haemodilution (haematocrit >0.22) 
was used with flow rates of 2.2-2.4 l/m2 and mean perfusion pressure of 50-85 mm 
Hg. Intermittent cold crystalloid cardioplegia was administered through the antegrade 
route. Peripheral and central anastomoses were constructed during single aortic 
occlusion. Cardioplegia solution consisted of magnesium 16 mmol/l and no extra 
magnesium substitution was given. 
 
4.2.2. POSTOPERATIVE CARE AND FOLLOW UP 
   After the operation patients were followed in the intensive care unit (ICU) and were 
weaned off the ventilator when they fulfilled the following criteria: hemodynamic 
stability, peripheral temperature more than 32oC, co-operativity, and no major 
bleeding. Chest drains were removed on the first postoperative day and the patients 
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were moved to the surgical ward when their hemodynamics and respiration were 
stable. In studies II, III and IV, postoperative continuous ECG monitoring was carried 
out during the whole period of hospital stay to detect all episodes of AF and twelve-
lead ECG was used to confirm the rhythm abnormality. The ECG recordings were 
checked daily by the surgeon. Postoperative potassium level was measured twice a 
day during the study period and potassium was administered as needed to keep the 
potassium serum concentration within normal range. Aspirin was administered 
100 mg daily starting on the first postoperative day. In studies II, III and IV, b-
blocking medication (metoprolol) was continued in every patient starting on the first 
postoperative day, and the dosage was titrated for a resting heart rate 60-90. No other 
anti-arrhythmic medication was given. In study I, b-blocking medication was used in 
patients who had no contraindications such as bradycardia or severe asthma. 
 
4.3. STUDY SETTINGS 
4.3.1.  LOGISTIC REGRESSION MODEL 
   Data from 3,676 consecutive patients were retrospectively analysed. Detailed pre-, 
peri- and postoperative data had been prospectively collected by a cardiologist and 
had been entered into a cardiac surgical database. On the basis of these data a 
multivariate logistic regression model was created. This model was validated 
prospectively in 1,107 patients. 
 
4.3.2.  ANALYSIS OF HEART RATE VARIABILITY 
   Function of the autonomic nervous system was evaluated by short-term 
measurements of HRV. HRV measurement was performed in the Department of 
Clinical Physiology the day before surgery. A commercial software package 
(CAFTS, version 3.3.9 Medicro Inc., Kuopio, Finland) was used for all data 
acquisition and analysis. Continuous ECG recording was performed in three different 
conditions: 
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1) Spontaneous breathing: ECG was recorded for a 10 min period during normal 
spontaneous breathing in supine position. 
 
2) Controlled breathing: ECG was recorded for a 10 min period during fixed 
breathing frequency of 0.2 Hz in supine position. 
 
3) After 2 min recording in supine position with normal breathing, the subject was 
passively tilted up to a 70 degree angle position for a period of 10 min. 
 
 Data were analysed by the CAFTS software package. The time domain analysis 
of HRV included standard deviation of normal-to-normal RR intervals (SDNN) and 
the square root of the mean squared differences of adjacent RR intervals (RMSSD) 
during a 5 min period free from ectopic beats. For the power spectral analysis, an 
autoregressive modelling with fixed model order of 14 was used. Spectral analysis of 
HRV included total power, high-frequency (HF) component (0.15 to 0.40Hz), low-
frequency (LF) component (0.04 to 0.15 Hz) and very low-frequency (VLF) 
component (0 to 0.04 Hz ). Thereafter, the LF/HF ratio and HF power in normalised 
units (HF nu), i.e. HF power/(Total power-VLF power)*100, was calculated. LF 
power was normalised as well (LF nu), i.e. LF power/(Total power-VLF power)*100. 
 
4.3.3. MEASUREMENT OF ATRIAL SIZES AND CONCENTRATIONS OF 
ATRIAL PEPTIDES 
   Preoperatively each patient had a transthoracic echocardiographic evaluation study 
by a cardiologist (HP Sonos 2500, Hewlett Packard, USA). The sizes of the left and 
right atria were measured in the apical four-chamber view. 
 Venous blood samples from the cubital vein, for the analysis of atrial natriuretic 
peptide (ANP), N-terminal natriuretic peptide (N-ANP) and brain natriuretic peptide 
(BNP), were taken preoperatively, and 18 hours and 28 hours postoperatively. ANP 
and BNP were extracted from plasma using SepPak C18 cartidges. N-ANP was 
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assayed directly from unextracted plasma. The radioimmunoassay protocols have 
been described previously for ANP (Vuolteenaho et al. 1985) and N-ANP 
(Vuolteenaho et al. 1992). The BNP assay was performed with the same protocol as 
ANP. The sensitivities of the ANP, N-ANP, and BNP assays were 1.0, 40 and 
0.5 pmol/l plasma, respectively. The ‘within and between’ assay coefficients of 
variation in each assay were <10 and <15%, respectively. The different assays were 
specific for the particular peptide. The ANP and N-ANP assays cross-reacted fully 
with proANP and the BNP assay with proBNP. With these methods, the following 
plasma levels (mean ± SD) were detected in healthy adult volunteers aged 20-55 
years: ANP 10.9 ± 4.0 pmol/l, BNP 3.8 ± 3.4 pmol/l and N-ANP 227 ± 84 pmol/l 
(Vuolteenaho et al. 1992) 
 
4.3.4.  HIGH-RATE ATRIAL PACING TEST 
   After cannulation, but before starting the cardiopulmonary bypass, two epicardial 
pacing electrodes (Flexon-0, Tyco Healthcare Finland, Helsinki, Finland) were 
sutured into the right atrial wall. One electrode was sutured to the sinoatrial node 
region and the other two centimetres away from it to the lateral wall of the right 
atrium. The interelectrode distance was the same for all patients. The right atrium 
was paced with an output programmed at two times the capture threshold using a rate 
of 200 beats per minute for 10 seconds. The rhythm was determined after the high-
rate pacing was stopped. Patients were ECG-monitored during the test and the test 
was determined positive if the pulse rate was irregular and there were no p-waves 
before the QRS complexes. If the patient was in sinus rhythm the test was repeated 
after one minute with a rate of 250 beats per minute. If sinus rhythm was still present 
after the pacing the test was repeated after one minute with a pacing rate of 300 beats 
per minute. Thereafter, the cardiopulmonary bypass was initiated. 
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4.4. STATISTICS 
   All the statistical procedures were performed by SPSS 9.0 statistical package (SPSS 
Inc., Chicago, Illinois, USA). Values are expressed as mean±SD unless otherwise 
indicated. In study II the distribution of power spectral analysis values was skewed 
and, therefore, log-transformed before statistical analysis. Differences in continuous 
and categorised variables were tested by unpaired t-test and chi-square, or Fischer`s 
exact test, respectively. Paired t-test was used to test differences of pre- and 
postoperative values of atrial peptides (study III). Correlation between those variables 
that were significant in the univariate analyses was tested by Pearson’s correlation 
(continuous variables) or Spearman’s rank order correlation (categorised or nominal 
variables). Only one clinically relevant variable was chosen for multivariate analysis 
in the case of correlation (p<0.05). If a variable predicted AF in univariate analysis it 
was entered into backward stepwise logistic regression analysis in order to assess the 
independent predictors of AF (studies I-III). In study I, model calibration (precision) 
was evaluated by the goodness-of-fit statistics (Hosmer and Lemeshow 1989). The 
discrimination abilities (accuracy) of the predictive model were assessed with the 
area under the receiver-operating characteristic (ROC) curve (Hanley and McNeil 
1983). The limit for statistical significance was p<0.05. 
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5.        RESULTS 
5.1. LOGISTIC REGRESSION MODEL 
   The majority of the patients were men (76.1%) and the mean age was 60.5 + 8.5 
years. Age distribution of the patients is presented in Figure 1. There were only four 
patients over 80 years of age.  The overall incidence of AF was 31%. The mean age 
of the patients with AF was 63.9 compared with 58.9 years for the patients that 
remained in sinus rhythm (SR). The incidence of AF in age groups is presented in 
Figure 1. 
 Univariate analysis identified several preoperative patient-related factors which 
had high association with postoperative AF. The preoperative demographics data are 
shown in Table 5 for patients with and without postoperative AF. 
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Figure 1: Age distribution of patients and the incidence of postoperative AF in each 
age group. 
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Table 5. Statistically significant preoperative and perioperative variables in 
univariate analysis associated with postoperative atrial fibrillation. 
 
Preoperative variable   
 
All patients  
N=3,676  
Mean (SD) or  
% of subgroup, N 
Sinus rhythm  
N=2,535  
Mean (SD) or  
% of subgroup, N 
Atrial fibrillation  
N=1,141  
Mean (SD) or  
% of subgroup, N 
p value;  
Patients in sinus 
rhythm vs. AF 
Age, years 60.5 (8.5)  58.9 (8.6)  63.9 (7.5)  <0.001 
BSA, m2  1.89 (0.17)  1.90 (0.17)  1.89 (0.17)  0.044 
EF % 63 (14.1)  63.6 (13.8)  61.8 (14.6)  <0.001 
Preoperative haemoglobin g/l 142.4 (12.8)  142.7 (12.7)  141.5 (12.9)  0.007 
Heart volume ml/m2 468 (82.3)  462.2 (82.1)  481.2 (81.3)  <0.001 
Gender ** ** ** 0.008 
Male 76.1%, 2,798 77.4%, 1,961  73.3%, 837   
Female 23.9%, 878 22.6%, 574  26.6%, 304   
NYHA class 3.1 (0.7) 3.1 (0.7) 3.2 (0.7) 0.010 
Unstable angina 28.7%, 1,056  27.3%, 693  31.8%, 363  0.005 
Current or ex- Smoker 54.3%, 1,996  55.6%, 1,410  51.3%, 586  0.016 
Serum creatinine level >119 mmol/l 4.8%, 177  4.2%, 107  6.1%, 70  0.012 
Dyslipidemia 59.2%, 2,178  61.5%, 1,560  54.2%, 618  <0.001 
Digoxin use preoperatively 4.9%, 180  3.6%, 92  7.7%, 88  <0.001 
Diuretic use preoperatively 11.9%, 438  10%, 256  16%, 182  <0.001 
History of TIA 5.5%, 202  4.9%, 124  6.8%, 78  0.017 
History of COPD 1.6%, 59  1.1%, 29  2.6%, 30  0.001 
EF < 50% 15.5%, 569  14.2%, 359  18.4%, 210  0.001 
     
Perioperative or early postoperative variables  
     
Need of IABP or inotropic support 
when weaning off the pump  
4.1%, 149  3.3%, 84  5.7%, 65  0.001 
Number of peripheral anastomoses  4.5 (1.2)  4.5 (1.2)  4.6 (1.2)  0.012 
Pump time  117.2 (41.5)  115.4 (40.9)  119.1 (41.2)  0.012 
Clamp time 100.1 (34.7)  98.8 (33.9)  101 (35.4) 0.037 
IABP or inotropic medication 
during the first 24 hours 
9.4%, 346  7.1%, 181  14.1%, 161  <0.001 
Temporary conduction disturbance 7.3%, 270  6.6%, 168  8.9%, 102  0.013 
Resternotomy because of bleeding 3.7%, 137  3.3%, 84  4.6%, 53  0.049 
BSA = body surface area; EF = ejection fraction; NYHA = New York Heart Association;TIA = transient 
ischaemic attack; COPD = chronic obstructive pulmonary disease; IABP = intra-aortic balloon pump. 
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    Increased age, high volume of the heart in preoperative chest x-ray, preoperative 
use of digoxin, and preoperative use of diuretics had the strongest association with 
postoperative AF. Other factors with significant association were ejection fraction 
less than 50%, female gender, unstable angina pectoris, no ex- or current smoking, 
increased level of serum creatinine and smaller NYHA class. 
 Perioperative and early postoperative data are presented in Table 5. Univariate 
analysis showed that increased number of peripheral anastomoses, long pump time, 
and long aortic cross-clamp time were highly associated with high incidence of 
postoperative AF. The need for inotropic support and temporary conduction 
disturbance had association with AF. 
Multivariate analysis identified five independent factors as predictor of postoperative 
AF (Table 6). 
 
 
Table 6.  Multivariate predictors of postoperative atrial fibrillation. 
 
Variable P value B OR 95% CI of OR 
Advanced age (continuous) <0.001 0.774 1.08 1.07 – 1.09 
Increased body surface area  
(categorised)  
0.006 0.0641 1.07 1.02 -1.12 
Decreased ejection fraction  
(categorised) 
0.048 0.0711 1.07 1.00 -1.15 
Digoxin use preoperatively 0.003 0.4986 1.64 1.18 -2.29 
IABP or inotropic medication  
during the first 24 hours 
0.013 0.3180 1.37 1.07 – 1.77 
 Constant –6.0296     
Hosmer-Lemeshow goodness of fit p=0.0684, Chi-square 14.5549, and degrees of freedom 8.  
CI = Confidence interval, IABP = Intra-aortic balloon pump, OR = Odds ratio 
 
 
 Old age was statistically the strongest predictor of AF with an odds ratio (OR) of 
1.1 for each increasing year above the lower border of the age range. Preoperative use 
of digoxin increased the risk of postoperative AF 1.6 fold.  The need of an intra-aortic 
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balloon pump (IABP) or the need of inotropic medication in the weaning off  
cardiopulmonary bypass, or during the first 24 hours postoperatively, increased the 
risk of postoperative AF 1.4 fold. For the regression analysis, body surface area 
(BSA) was divided into ten (10) categories: <1.5m2, 1.5-1.6 m2, 1.6-1.7 m2, and >2.3 
m2. The ejection fractions were arbitrarily grouped as well as follows: >60%, 50-
60%, 40-50%, 30-40% and less than 30%. Increasing body surface area and low 
ejection fraction were independent risk factors for postoperative AF.  
 Model calibration (precision) statistics are shown in Table 6 and the results of 
ROC analysis in Figure 2. The area under the ROC curve was 0.690, 95% confidence 
interval 0.657-0.724, and p<0.001. The negative predictive value of the model was 
71.5% and the positive predictive value was 54.7% (cut off level 0.5). The 
retrospective derivation patient series was not quite comparable with the prospective 
validation series: the prospective patients were older (62.9 + 9.3 vs. 60.3 + 8.5 years, 
p<0.001), they had lower preoperative haemoglobin values (138.6 + 13 vs. 142.6 + 
12.7, p<0.001), shorter perfusion time (94.3 + 31.1 vs. 114.4 + 38.2 min, p<0.001), 
shorter aortic cross clamp time (82.6 + 25.6 vs. 97.9 + 32.2 min, p<0.00), and the 
number of peripheral anastomoses was lower (4.1 + 1.1 vs. 4.5 + 1.2, p<0.001). 
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Figure 2.  Discrimination power of the regression model predicting postoperative AF 
from data of preoperative phase and of the first 24 postoperative hours.  
The model described in Table 2 was tested in the prospective validation patient 
series, N=1,107.  The area under the ROC curve was 0.690, 95% confidence interval 
0.657-0.724, and p<0.001. 
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 Postoperative outcome of the patients with and without AF is presented in Table 
7. Postoperative AF was associated with increased risk of complications. Patients 
with postoperative AF had a 2.3-fold increased incidence of stroke than patients 
without AF. The rate of confusion or postoperative psychosis was also significantly 
higher in the patients with AF. The patients with AF had a significantly greater 
number of serious gastrointestinal complications (pancreatitis, cholecystitis, 
ischaemic bowel complications or gastrointestinal bleeding). 
 
 
Table 7. Relationship of postoperative events to atrial fibrillation. 
 
Variable All patients  
N = 3,676  
Mean (SD) or  
% of subgroup 
Sinus rhythm  
N = 2,535  
Mean (SD) or % of 
subgroup 
Atrial fibrillation  
N = 1,141  
Mean (SD) or % of 
subgroup 
p value;  
Patients in 
sinus rhythm 
vs. AF 
Postoperative stroke 0.8% 0.6% 1.4% 0.008 
Confusion or 
psychosis  
1.8% 1.0% 3.3% <0.001 
Postoperative TIA 0.5% 0.4% 0.7% 0.152 
Multiple organ 
failure 
0.7% 0.7%  0.6% 0.742 
Anuria 0.9% 0.8% 1.1% 0.300 
Severe GI 
complication 
0.5% 0.3% 1.0% 0.005 
Readmission to ICU 2.2% 1.1%  4.6% <0.001 
30-day mortality 1.4% 1.6% 1.0% 0.121 
Postoperative length 
of stay in ICU, days 
1.6 (3.4) 1.4 (2.8) 2.2 (4.3) <0.001 
Postoperative length 
of hospital stay, 
days 
6.8 (4.7) 6.3 (3.7) 7.8 (6.1) <0.001 
TIA= Transient ischaemic attack; GI= gastrointestinal; ICU= Intensive care unit
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 Readmission rate to the intensive care unit (ICU) of the patients with AF was 
more than 4-fold compared to the patients without AF. The length of the stay in the 
ICU as well as in the hospital was also significantly longer in the patients with 
postoperative AF. 
 
5.2. ANALYSIS OF HEART RATE VARIABILITY 
 HRV was assessed in 100 patients. Four patients were excluded from the 
analysis because they were operated on with beating heart without cardiopulmonary 
bypass due to extensive calcification of the ascending aorta. Four patients had to be 
excluded from the HRV analysis, because there were not sufficiently long periods 
free of ectopic beats for the analysis. Therefore 92 patients formed the final study 
population. 
 The majority of the patients were males (n=70). Seventeen patients had diabetes 
and 2 patients used digoxin preoperatively. The average age was 61.7± 9.9 yrs (range 
40-85 yrs).  All the patients had b-blocking agent medication preoperatively. Thirty 
(32.6%) patients developed AF postoperatively while 62 (67.4%) remained in SR. 
The time of occurrence of postoperative AF was 59±23 hours (range 12-115 hours) 
from the operation. There were no postoperative deaths in the study group. One 
perioperative stroke occurred. There were 4 perioperative myocardial infarctions 
(new Q-wave and increases in serum levels of MB isoenzyme of creatinine kinase); 3 
of these were in the AF group and 1 in the SR group. The clinical and operative 
characteristics of the patients with and without postoperative AF are presented in 
Table 8. 
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Table 8. Clinical characteristics of patients with AF and with SR after CABG. 
 
Preoperative Characteristic SR Patients, N=62 
N, (%) 
AF Patients, N=30 
N, (%) 
univariate p 
Age, years 59.7±9.7 66.0±9.0 0.004 
Gender  (men/women) 48/14 22/8 0.667 
Body mass index 27.0± 3.1 28.5 ± 3.7 0.047 
Current tobacco use 6, (9.7%)  4, (13.3%) 0.597 
Diabetes 8, (12.9%)  9, (30.0%) 0.048 
COPD 2, (3.2%) 4, (13.3%) 0.066 
Hypertension 26, (41.9%) 18, (0.60%) 0.104 
Digoxin therapy 1, (1.6%) 1, (3.3%) 0.596 
History of MI 28, (45.2%) 10, (33.3%) 0.280 
Unstable angina 5, (8.1%) 3, (10.0%) 0.757 
History of claudication 3, (4.8%) 4, (13.3%) 0.150 
Creatinine (µg/ml) 91±11 94±17 0.321 
Haemoglobin g/l 141± 11 135±13 0.020 
Perioperative Characteristic    
Cardiopulmonary bypass time, 
min 
90 ± 28 99±38 0.239 
 Cross-clamp time, min 80±25 85±30 0.438 
Number of bypass grafts  4.2± 1.2 4.3±1.2 0.567 
CK-MB mass (µg/l) 30 ±19 30 ±18 0.996 
COPD = chronic obstructive pulmonary disease, CK-MB mass = First postoperative creatinine kinase-MB 
mass, MI = myocardial infarction, the values are mean ± SD, univariate p is between the SR and AF groups. 
 
 
    
   Univariate analysis showed that increased age, low preoperative haemoglobin 
value, diabetes, and high body mass index were associated with high incidence of 
postoperative AF. Multivariate analysis identified two independent factors as 
predictors of postoperative AF. Old age was the strongest predictor of AF with an 
odds ratio (OR) of 1.06 for each increasing year above the lower border (46 years) of 
the age range (p=0.03, 95% CI 1.0061-1.1248). Body mass index (BMI) was the 
other independent predictor of postoperative AF (OR 1.18 per unit, p=0.02, 95% CI 
1.0259-1.3739)
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   Heart rate, SDNN or RMSSD did not differ significantly between AF and SR 
groups when tested either with spontaneous or controlled breathing. None of the 
spectral analysis measures (total power, VLF power, LF power and HF power) 
differed significantly either. In both groups, heart rate increased and SDNN decreased 
after tilting towards upright position, but there was no statistical difference between 
the groups. In power spectral analysis, total power and all of its components 
decreased after tilting up both in AF and SR groups but there was no statistical 
difference between the groups. There was no statistical difference between the groups 
in LF/HF ratio in any of the differing conditions. The results of HRV analysis are 
summarised in Table 9. Multivariate analysis did not identify any parameter of HRV 
analysis as an independent predictor for postoperative AF. Exclusion of diabetic 
patients from analysis of HRV did not significantly affect the result. Also exclusion 
of the patients who had history of myocardial infarction did not affect the result. 
Exclusion of the patients with unstable angina pectoris did not affect the result either. 
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Table 9. Result of HRV analysis in AF and SR patients. 
 
Characteristic SR Patients, n=62 AF Patients, n=32 univariate p 
Spontaneous breathing    
Heart rate (beats/min) 61.8±9.2 58.6±8.5 0.088 
SDNN 28.3±15.7 33.0±16.1 0.192 
RMSSD 21.5±14.6 26.4±18.3 0.172 
Total power 6.3±1.1 6.7±1.0 0.137 
VLF power 5.6±1.2 5.9±1.0 0.131 
LF power 4.8±1.3 4.8±1.3 0.988 
HF power 4.5±1.4 4.9±1.5 0.228 
LF/HF ratio 1.1±0.4 1.0±0.3 0.196 
LF nu 8.3±5.3 11.0±11.0 0.203 
HF nu 7.4±4.3 10.6±9.6 0.105 
    
Controlled breathing    
Heart rate (beats/min) 63.2±9.0 59.7±9.9 0.093 
SDNN 27.2±14.2 26.8±15.1 0.894 
RMSSD 21.7±17.4 22.0±18.6 0.947 
Total power 6.2±1.1 6.1±1.1 0.626 
VLF power 5.4±1.0 5.2±1.0 0.417 
LF power 4.5±1.2 4.2±1.4 0.349 
HF power 4.7±1.5 4.8±1.5 0.880 
LF/HF ratio 1.0±0.3 0.9±0.3 0.231 
LF nu 7.2±4.4 6.6±4.1 0.544 
HF nu 7.1±4.0 7.2±4.6 0.924 
    
Standing    
Heart rate (beats/min) 71.1±10.8 68.9±9.4 0.351 
SDNN 26.1±12.9 23.0±10.0 0.269 
RMSSD 15.2±14.8 11.8±7.0 0.248 
Total power 6.2±1.0 5.9±0.9 0.272 
VLF power 5.5±1.0 5.5±0.9 0.912 
LF Power 4.6±1.3 4.0±1.1 0.059 
HF power 3.6±1.4 3.2±1.3 0.210 
LF/HF ratio 1.4±0.5 1.3±0.5 0.604 
LF nu 11.4±8.4 12.8±7.3 0.458 
HF nu 8.2±5.0 9.6±5.1 0.262 
The values of power spectral analysis are logtransformed. HF = high frequency, LF = low f requency,  
nu = normalised unit, RMSSD = the square root of the mean squared differences of adjacent RR intervals, 
SDNN = standard deviation of normal-to-normal RR intervals, VLF = very low frequency.
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5.3. MEASUREMENT OF ATRIAL SIZES AND CONCENTRATIONS                        
               OF ATRIAL PEPTIDES 
 Twelve patients were excluded from the analysis. The reasons for exclusion 
were: 4 patients had unplanned mitral valve procedure, 5 patients unexpectedly were 
operated on without cardiopulmonary bypass with beating heart due to calcification 
of ascending aorta, and 3 patients had incomplete data of atrial peptides. Thus, 88 
patients formed the study population. 
 Seventy eight percent of the patients were male and their average age was 
61.8 ± 9.9 years. All patients had b-blocking medication preoperatively. 
Postoperative AF occurred in 31 of 88 (35.2%) patients. The average time from the 
operation to the first AF episode was 56 ± 22 hours. The patients` demographics and 
operative data are summarised in Table 10. There were no hospital deaths in the study 
group. Two patients, both in the sinus rhythm (SR) group had to be reoperated due to 
postoperative bleeding. There were no perioperative myocardial infarctions or 
postoperative low output syndromes in the study group. Two perioperative strokes 
occurred, one in each group. One superficial sternal wound infection occurred in the 
AF group. 
 Atrial dimensions and other results of transthoracic echocardiographic 
assessment and the values of ANP, N-ANP and BNP levels are presented in Table 11. 
Results of the analysis of atrial areas are illustrated in Figure 3. 
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Table 10. Demographic, operative and postoperative data and univariate p value. 
 
Variable SR group 
N=57, (%) 
AF group 
N=31, (%) 
P value 
Age (years) 59.6±9.9 65.9±8.8 0.003 
Female gender (n, %) 12, (21.1%) 7, (22.6%) 0.87 
BMI 27.4±3.1 28.7±3.7 0.07 
BSA (m2) 1.92±0.17 1.97±0.19 0.21 
COPD (n) 2, (3.5%) 3, (9.7%) 0.23 
Hypertension (n, %) 22, (38.6%) 18, (58.1%) 0.08 
Diabetes (n, %) 7, (12.3%) 9, (29.0%) 0.05 
Prior MI (n, %) 24, (42.1%) 12, (38.7%) 0.76 
NYHA class 2.5±0.7 2.8±0.7 0.08 
Preop. digitalis (n, %) 0, (0.0%) 1, (3.2%) 0.17 
Preop. haemoglobin value (g/l) 141±11 136±13 0.062 
Preop. creatinine value (mmol/l) 90±15 95±18 0.23 
Smoking (n, %) 5, (8.8%) 4, (12.9%) 0.54 
Urgent operation (n, %) 4, (7.0%) 3, (9.7%) 0.66 
Number of Anastomoses (n) 4.2±1.2 4.3±1.2 0.76 
Perfusion time (min) 91±27 94±30 0.75 
Aortic cross-clamp time (min) 82±24 82±28 0.92 
RCA by-pass (n, %) 46, (80.7%) 25, (80.6%) 0.99 
Postop. CK-MB mass (µg/l) 27±16 29±18  0.59 
Ventilation > 24 h (n, %) 0, (0.0%) 1, (3.2%) 0.17 
Resternotomy (n, %) 2, (3.5%) 0, (0.0%) 0.29 
BMI=body mass index, BSA = body surface area, COPD = chronic obstructive pulmonary disease, 
NYHA=New York Heart Association, CK-MB mass = creatinine kinase-MB mass, the values are 
mean ± SD or n (%). 
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Table 11. Atrial areas and values of ANP, N-ANP and BNP and univariate p value. 
 
Variable SR group AF group  p value 
Right atrium, cm2 /m2 8.9±1.8 10.2±2.3 0.004 
Left atrium, cm2/m2 9.2±2.3 10.9±2.7 0.002 
Diameter of left ventricle wall, mm 11.8±2.2 12.8±2.5 0.06 
LVEDD, mm 52.0±6.7 50.7±6.5 0.37 
LVESD, mm 33.8 ±5.4 32.4 ±6.1 0.26 
Preop. ANP, pmol/l 57±28 79±58 0.016 
Preop. N-ANP, pmol/l 337±147 426±230 0.03 
Preop. BNP, pmol/l 10±10 14±16 0.15 
1. postop. ANP, pmol/l 125±56 155±78 0.04 
1. postop. N-ANP, pmol/l 536 ±244 697±315 0.01 
1. postop. BNP, pmol/l 36±19 36±17 0.93 
2. postop. ANP, pmol/l 110±41 148±91 0.008 
2. postop. N-ANP, pmol/l 558±237 772±397 0.002 
2. postop. BNP, pmol/l  35±19 33±15 0.650 
LVEDD=left ventricle end diastolic diameter, LVESD= left ventricle end systolic diameter, ANP= 
atrial natriuretic peptide, N-ANP=N-terminal natriuretic peptide, BNP=brain natriuretic peptide, 
preop=preoperative, postop=postoperative. Values are expressed as mean ± SD. 
 
 Old age and increased left and right atrial dimensions were associated in 
univariate analysis with increased risk for postoperative AF. Increased level of ANP 
and N-ANP both preoperatively and postoperatively were also associated with 
increased risk for AF. There was no significant association between the level of BNP 
and the risk for postoperative AF. The level of all atrial peptides increased 
significantly after the operation compared with preoperative concentrations. There 
was a significant correlation between age and the level of N-ANP (r=0.451 and 
p<0.01). The correlation is illustrated in Figure 4. 
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Figure 3. Results of analysis of atrial areas. 
Black boxplots represents patients who remained in sinus rhythm and open boxplots 
represents patients who went into atrial fibrillation. P-values are less than 0.05 
between AF and SR groups both in the areas of right and left atrias. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Correlation between patient’s age and value of preoperative N-ANP. 
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 Diabetes associated in univariate analysis with increased risk for postoperative 
AF and there was a trend indicating association between high body mass index and 
postoperative AF, as well as between low preoperative haemoglobin value and 
postoperative AF. 
 The sizes of the left and right atria correlated significantly (r=0.59, p<0.001) and 
only the size of left atrium was taken to multivariate analysis. The left atrium was 
chosen because of left atrial predominance in the initiation and maintenance of AF 
(Haissaguerra et al. 1998). Atrial size did not correlate with the level of ANP or N-
ANP. The correlation between ANP and N-ANP was strong (r=0.64, p<0.001). 
Therefore only preoperative N-ANP value was taken to multivariate analysis. 
 Two variables were found to be independent predictors of postoperative AF. 
Age was one predictor of AF with an odds ratio (OR) of 1.07 for each increasing year 
above the lower border of the age range (p=0.02 and 95% CI 1.01-1.12). The other 
independent predictor was the cross sectional area of the left atrium. Each increasing 
cm2 of left atrial area increased the risk of AF 1.29 fold (p=0.01 and 95% CI 1.05-
1.57). Diabetes was not an independent predictor for postoperative AF in multivariate 
analysis. 
 
5.4. HIGH-RATE ATRIAL PACING TEST 
   The mean age of all patients was 63.4 ± 8.3 years (range 41-77 years). Seventeen 
(21%) patients were female. All except 2 patients had b-blocking medication 
preoperatively and b-blocking medication was given to all patients postoperatively. All 
patients underwent CABG without additional procedures and the mean number of distal 
anastomoses was 4.1 ± 1.0. There was no mortality in the study group. One patient 
(1.3%) had a perioperative stroke and another patient (1.3%) returned to the operating 
room because of postoperative bleeding.    
 During the postoperative period AF developed in 28 patients (35%). The first AF 
episode appeared on average 52 hours postoperatively (range 5-100 hours). AF was 
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treated medically and all the patients were in sinus rhythm at the time of discharge. 
Patients who developed AF tended to be older (p=0.09), to have a higher creatinine 
kinase-MB mass postoperatively (p=0.05) and were more often female (p=0.08) 
compared to patients who remained in sinus rhythm (Table 12). 
 
 
Table 12. Preoperative, perioperative and postoperative characteristics of patients. 
 
Characteristics SR,  
N=52, (%) 
AF,  
N=28, (%) 
p value 
Age (years) 62.3±8.2 65.5±8.1 0.09 
Female gender (n) 8, (15.4%) 9, (32.1%) 0.08 
Ejection fraction (%) 64±14 66±12 0.65 
Hypertension (n) 28, (53.8%) 19, (67.9%) 0.22 
COPD (n) 1, (1.9%) 1, (3.6%) 0.65 
Diabetes (n) 11, (21.1%) 7, (25.0%) 0.69 
Pump time (min) 83±29 90±34 0.37 
Cross-clamp time (min)  76±30 79±29 0.62 
Number of anastomoses (n) 4.1±1.0 4.1±1.0 0.85 
Right coronary bypass 47, (90.4%) 23, (82.1%) 0.29 
CK-MB mass (µg/l) 29±18 46±58 0.05 
AF = atrial fibrillation, COPD = chronic obstructive pulmonary disease,  
CK-MB mass = First postoperative creatinine kinase-MB mass, SR = sinus rhythm. 
The values are mean ± SD or N (%).
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   High-rate atrial pacing test induced AF in 27 (33.7%) patients (Figure 5). Nine 
patients were inducible with the pacing rate of 200 beats per minute, 14 patients with 
the rate of 250 per minute, and 4 patients with the rate of 300 per minute. Of the 28 
patients who developed AF during the postoperative period, 17 patients were inducible 
to AF in the test. Thus, the sensitivity of the test was 0.61. Of the 52 patients who did 
not develop AF postoperatively, 42 patients were non-inducible in the pacing test, 
giving a specificity of 0.81. The positive and negative predictive values of the test were 
0.63 and 0.79, respectively. The rate of pacing which induced the AF, did not influence 
the sensitivity or specificity, when analysed separately. 
 
 
 
                                          80 patients 
 
 
             27 patients induced to                  53 patients not induced to 
               AF in test                                          AF in test 
 
 
            17 postoperative AF                          11 postoperative AF 
                 63%                                                   21% 
 
  
 
Figure 5. Results of high rate atrial pacing test. 
       AF= Atrial fibrillation, SR= Sinus rhythm. 
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6. DISCUSSION 
6.1. MATERIALS 
   In study I the retrospective patient population comprised all patients who had 
isolated CABG during the study period, apart from those patients who had AF 
preoperatively. The number of patients in our study is one of the biggest published 
patient material concerning AF after CABG. Because of the large number of patients, 
the sample is a good representation of the general patient population undergoing 
CABG. The group of 1,107 patients, in which the logistic regression model was 
validated, was not completely comparable in regards to age, preoperative 
haemoglobin values, perfusion time, aortic cross clamp time, and the number of 
peripheral anastomoses. This may be one reason why the discriminating power of the 
model was not exceptionally good. 
 In studies II and III the patients with the history of myocardial infarction less 
than one month preoperatively and the patients whose left ventricular ejection 
fraction were less than 50% were excluded. We did exclusions in order to minimise 
the factors, which might have influenced HRV and atrial peptide concentrations, and 
to achieve as uniform a study population as possible. A consequence of these 
exclusions the study cohort (II and III) does not represent completely the patient 
population undergoing CABG nowadays. A similar conclusion can be drawn in study 
IV in which the patients with unstable angina pectoris were excluded for safety 
reasons. 
 
6.2. EVALUATION OF THE METHODS 
   Surgical and anaesthesiological methods that we used in the patients’ treatment are 
generally accepted and widely used. We used antegrade crystalloid cold cardioplegia for 
all patients in the study groups. In many other cardiac surgical centres other forms of 
cardioplegia are used, but the type of cardioplegia does not seem to have an effect on 
the incidence of postoperative AF (Butler 1993a, The warm heart investigators 1994, 
Pehkonen et al. 1995). 
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   HRV was measured in the Department of Clinical Physiology under standardised 
physiological conditions. In HRV measurement, transthoracic echocardiographic 
evaluation, and analysis of concentrations of ANP, N-ANP and BNP, we used 
methods that,  are widely utilised in clinical practise. 
   We performed an intraoperative high-rate atrial pacing test just before starting 
cardiopulmonary perfusion. Some intra-operative factors might have an influence on 
the incidence of postoperative AF, therefore the diagnostic accuracy of the test would 
be even better if it were performed after finishing cardiopulmonary perfusion. But 
just after cardiopulmonary bypass myocardium is vulnerable and the AF induced by 
high-rate pacing test would be very harmful. There was no morbidity related to the 
pacing test in our study. 
 
 
6.3. PREDICTORS OF AF AND ITS IMPACT ON OUTCOME 
 We found old age to be an independent predictor of postoperative AF (I, II, III). 
Old age has consistently predicted a high incidence of AF after CABG (Table 1). 
Increased age causes cardiac dilatation, muscle atrophy, conduction tissue decrease, 
and fibrosis in atria (Lie et al. 1988, Kitzman et al. 1990). These age-related changes 
may be responsible for increased risk for AF after CABG. 
 Decreased left ventricle ejection fraction was an independent predictor for post-
CABG AF in our study (I). Poor left ventricular function is associated with a greater 
risk for the development of AF in non-surgical patients (Kannel et al. 1982), but, 
surprisingly, no other study has reported it as predictor of AF after CABG. 
 The need for IABP or the need for inotropic medication either when weaning off 
cardiopulmonary bypass, or anytime during the first 24 hours after operation was an 
independent risk factor for postoperative AF in our study (I). This correlation has also 
been found by other authors (Aranki et al. 1996, Almassi et al. 1997). Probably the 
increased risk of AF among patients requiring IABP therapy is not caused by IABP 
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itself, but it is related to other factors concurrent to IABP therapy: the use of inotropic 
agents, increased sympathetic activity, and heart. Thirty-day mortality was not 
different between patients with and without failure. 
 Preoperative digoxin use was independent predictor for postoperative AF in our 
study (I). This association between preoperative digoxin use and post-CABG AF has 
been found by some authors (Creswell et al. 1993, Almassi et al. 1997), but there are 
also contrasting findings (Hashimoto et al. 1991). It is apparent that in our study (I) 
digoxin was used for AF prophylaxis for many patients and, therefore, it actually 
reflects the increased risk related to previous episodes of AF paroxysm. 
Unfortunately, the previous AF paroxysms were not recorded in the cardiac surgical 
database. 
 We found that a large BSA was an independent predictor of postoperative AF (I). 
The large number (3676) of patients in the analysis make it unlikely that the caused 
by chance. We are not aware of any other study in which BSA was tested as a 
predictor of AF. We cannot find a plausible explanation as to why larger BSA 
predicts postoperative AF. 
 High body mass index was independent predictor for postoperative AF in study 
II but not in study I. Contrary to our result, Jideus et al. found that low BMI was 
independent predictor of AF after CABG (Jideus et al. 2000). However, the results of 
Jideus et al. and our own in study II are not conclusive and may be simply a result of 
the small number of patients in the studies. In our analysis of 3,676 patients (I) BMI 
did not differ between AF and SR groups either in univariate or multivariate analysis. 
 More postoperative complications were found in AF patients (I). The most 
serious complication of postoperative AF was stroke. The limitation of our study (I) 
was that we were not able to determine the exact timing of postoperative AF and 
stroke from our data, so it is difficult to draw conclusion if AF was predisposing 
factor for stroke, or whether the AF occurred after the stroke. However, postoperative 
AF was associated with a 2.3 fold increased risk of stroke (I). This is in agreement 
with other studies where postoperative AF has been an independent risk factor for 
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systemic embolic events and postoperative stroke (Creswell et al. 1993, Chung 1995, 
Aranki et al. 1996, Almassi et al. 1997). We also found that postoperative confusion 
or psychosis is related to postoperative AF (I). One possible explanation is that AF 
decreases the cardiac output and leads to hypoxemia, which might be the root cause 
of the confusion. The patients with AF had significantly more gastrointestinal 
complications than patients who remained in sinus rhythm (I). The plausible 
explanation for this is that low cardiac output during AF leads to ischaemia of the 
splanchnic area, and ischaemia is an initiating factor for gastrointestinal 
complicationspostoperative AF (I). Postoperative AF was associated with both a 
greater readmission rate to the ICU and longer stays in the ICU and the surgical ward 
(I). This finding has been reported by other investigators (Creswell et al. 1993, 
Aranki et al. 1996, Mathew et al. 1996, Almassi et al. 1997). 
 
6.4. LOGISTIC REGRESSION MODEL 
 The accuracy of the predictive model was good according to Hosmer-Lemeshow 
statistics, but its discriminative power was not very good since the area under the 
ROC curve was below 0.75. There were significant changes in the age of the patient 
population, the duration of the operation from years 1992-1996 to 1998-1999 and the 
number of peripheral anastomoses. Some systematic changes of these variables might 
have influenced the discriminative power of the model. It is evident that there are 
other factors influencing the occurrence of postoperative AF than those included in 
the model. The positive predictive power of our model is comparable to the 
predictive power of signal averaged P-wave duration (0.55 vs. 0.34-0.65, 
respectively, Table 4.), but the negative predictive power is lower (0.72 vs. 0.82-0.87, 
respectively). 
 Discriminative power of the model appears at the moment to be not high enough 
for clinical purposes. In addition, one factor in the model (IABP or inotropic use 
during the first 24 hours after CABG) is not known preoperatively and that makes the 
clinical use of the model difficult in practice. According to the literature (Table 4) 
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signal averaged P-wave duration is clearly a predictive factor for postoperative AF, 
and, in addition, left atrial size in preoperative echocardiography predicts 
postoperative AF (III). If these two variables were included in the regression model, 
the discriminate power of the test would be higher.  
 
6.5. HEART RATE VARIABILITY 
 We showed that a short-term preoperative analysis of HRV under standardised 
physiological conditions couldnt reliably identify patients at high risk for AF after 
CABG. The HF component of HRV corresponds to respiratory induced variations of 
heart rate and is mainly under vagal influence. The LF component of HRV is 
considered to be mainly a measure of cardiac sympathetic control (Malliani et al. 
1991). The LF/HF ratio is thought to be marker of the sympathovagal balance. In our 
study values of LF/HF increased both in AF and SR groups in due to sympathetic 
activation induced by passive tilt but there was not a difference between groups. 
  Two earlier studies evaluated preoperatively the risk of postoperative AF after 
CABG with HRV. Frost et al. analysed HRV of a 24-hour preoperative Holter 
monitoring performed in 102 CABG patients (Frost et al. 1995d). They calculated the 
percentage of successive RR interval differences >6% (vagal index) and found it 
significantly lower in patients developing AF while the overall HRV was the same 
between AF and SR groups. They concluded that isolated reduction in the basic vagal 
modulation causes an autonomic imbalance in patients prone to develop AF after 
CABG. Our results are not in agreement with the results of Frost et al. While the 
vagal index correlated with the power of the HF component in spectral analysis of 
HRV, we did not recognise a difference in HF power between the AF and SR groups. 
Frost et al. performed their analysis of HRV in 24-hour monitoring and we in 5 
minutes periods under three different conditions. This difference in the lenght of 
recording periods does not explain the different results, since both studies measured 
short-term HRV related to respiration. Jideus et al. did not find any difference in 
preoperative time and frequency domain variables between the patients who went 
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into AF and those who remained in SR (Jideus et al. 2001). This is in agreement with 
our study. However, they found that a diminished circadian variation in HRV before 
surgery indicated propensity for AF. The above-mentioned studies were based on the 
24-hour monitoring of HRV. Long-term measures of HRV represent responses of 
cardiac autonomic regulation to challenges of daily life and a limitation to 
interpreting these findings is that these challenges are not controlled, the recordings 
are not stationary and the recording conditions cannot be standardised. These 
standardisation problems could be solved by using an assessment of short-term HRV. 
In addition, in the risk assessment of post-CABG, AF long-term HRV measurement 
requires additional resources and, therefore, it is not clinically feasible. 
 Two other studies have evaluated HRV preceding onset of AF after CABG 
(Dimmer et al. 1998, Hogue et al. 1998). Dimmer et al. found that LF/HF ratio was 
initially significantly lower in their AF group compared to the SR group and it was 
followed by a significant increase compared to the initial values in AF patients. This 
study showed that changes of autonomic tone rather than autonomic tone itself were 
important indicators before AF onset. Because these changes of autonomic tone 
happened within minutes or an hour, it is obvious that they cannot be recognised 
when analysing HRV a day before surgery as we did. Hogue et al. observed either 
lower or higher measures of HRV before AF after CABG, a finding consistent with 
divergent autonomic conditions before AF onset. They thought that in some patients 
heightened sympathetic tone is present before AF but in others, either higher vagal 
tone or dysfunctional autonomic heart rate control is present before AF onset. In 
order to find those patients at high risk of AF after CABG, postoperative assessment 
of HRV is not feasible. It shows the risk of AF just prior to its onset, when any 
prophylactic actions would be too late and, furthermore, it requires so many 
resources, that it is practically impossible to apply clinically. 
 Diabetic autonomic neuropathy may impact heart rate dynamics (Freeman et al. 
1991). Exclusion of diabetic patients from the analysis did not significantly affect the 
results in our study. The LF power decreases during treatment with b-blocking agents 
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(Akselrod et al. 1981). All patients in our study group were on b-blocking medication 
on the time of HRV analysis. It is possible that withdrawal of b-blockade before 
HRV testing would have affected the results but, practically, it was not feasible. In 
this respect our study group was uniform and corresponds well with the clinical 
setting as most of the patients coming to CABG have b-blocking medication 
preoperatively. It has been shown that myocardial infarction may decrease HRV 
(Bigger et al. 1992). We also analysed HRV after exclusion of patients with a history 
of myocardial infarction, without significant effect on the result. 
 
6.6. ATRIAL SIZES 
 Left atrial enlargement was an independent predictor of postoperative AF in the 
present study (III). Atrial dilatation is associated with structural changes in the atrial 
wall and, therefore, it is argued that the distribution of atrial refractoriness is not 
uniform. Abnormal dispersion of refractoriness makes the atria more vulnerable to 
development of AF after cardiac surgery (Sato et al. 1992). Our results are in 
agreement with Ducceschi et al. who found that left atrial enlargement in 
transthoracic echocardiographics assessment was the strongest predictor of 
postoperative AF in CABG patients (Ducceschi et al. 1999). The same finding was 
reported by Giri et al. in patients undergoing CABG, valve surgery, or both. Asher et 
al. found left atrial enlargement to be an independent predictor of AF occurring early 
after the cardiac valvular surgery (Asher et al. 1998). 
 There are also opposite findings. Jideus et al. did not find atrial enlargement to 
predict AF after CABG in a study involving 80 patients (Jideus et al. 2000). We 
cannot find a plausible explanation for this difference between the results of their 
study and ours. Zaman et al. also did not find association between atrial enlargement 
and AF after CABG, but their study comprised only 64 patients and the study was a 
subgroup of larger study (Zaman et al. 2000). Neither was a difference found in left 
atrial transverse diameter measured using transthoracic echocardiography between 
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patients who went into AF after CABG compared to patients who remained in SR 
(Stafford et al. 1997). 
 It is evident that the predictive value of left atrial size alone is not accurate 
enough for clinical purposes to identify the patients at high risk for AF after CABG. 
However, if left atrial size were included in the regression model (I), the discriminate 
power of the model would be higher. 
 
6.7. ATRIAL PEPTIDES 
   Preoperative concentration of ANP and N-ANP were predictors of postoperative 
AF with univariate analysis, but they did not remain independent predictors of AF 
with multivariate analysis. We found a correlation between the patients` age and the 
level of N-ANP, and this correlation was found also in the N-ANP assessment of 
healthy subjects (Wang et al. 2002). Thus, both the patient’s age and the level of N-
ANP could not be taken into the same multivariate analysis. The main stimulus of 
release of N-ANP prohormone from the atrium is atrial wall stress (Edwards et al. 
1988). The association between elevated N-ANP levels and postoperative AF is 
caused by left atrial wall stress. Age-related changes like fibrosis in the atria 
increases atrial wall stress and stimulates the release of ANP prohormone. This may 
explain the correlation between increased age and increased level of N-ANP. Another 
reason might be the decrease in the clearance of natriuretic peptides from plasma in 
elderly patients, even in the absence of renal dysfunction (Wang et al. 2002). 
 In non-surgical patients, plasma ANP and N-ANP have been reported to be 
raised in patients with heart failure and to increase further as the severity of the 
disease progresses (Burnett et al. 1986, Raine et al. 1986). N-ANP is a marker for 
symptomless left ventricular dysfunction (Lerman et al. 1993). Therefore, we 
excluded patients who had an ejection fraction of less than 50% from our study, in 
order to exclude known left ventricular dysfunction as a reason for any increased 
level of ANP. In addition it is known that ANP and N-ANP levels are markedly 
increased in patients with acute myocardial infarction (Jougasaki et al. 1990, 
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Svanegaard et al. 1992) and thus we also excluded patients who had had myocardial 
infarction within 30 days prior to the operation. Yamada et al. have shown in non-
surgical patients that elevated ANP level is a predictor of paroxysmal AF in patients 
with congestive heart failure (Yamada et al. 2000). However, in our study ANP and 
N-ANP correlated with age, and they were not independent predictors of AF when 
adjusted for age. Jideus et al. did not find any association between preoperative 
values of ANP or N-ANP and AF after CABG (Jideus et al. 2000). 
 The level of N-ANP and ANP increased significantly after the operation 
compared with the preoperative values. This finding was in agreement with the result 
of other investigators (Jideus et al. 2000). Surgical trauma of atria and atrial wall 
stress because of fluid retention are the most plausible explanations for this change. 
 Preoperative atrial enlargement and concomitantly elevated preoperative plasma 
levels of atrial natriuretic peptides indicate an existence of pathophysiologic substrate 
for postoperative AF. The elevated levels of ANPs suggest that any pathophysiologic 
mechanism leading to an increase in atrial wall stress confer predisposition to 
electrical chaos and fibrillation. Increased postoperative level of the peptides 
indicates the same mechanism is significant at initiation of the AF. The patients with 
left ventricular systolic dysfunction were excluded in the present study (III). 
However, not only systolic but also diastolic dysfunction may cause an increase in 
filling pressure and an increase in atrial wall stress. Due to the wide overlapping of 
the plasma concentrations of the atrial peptides between the patients who went into 
AF and those who remained in SR, the preoperative peptide measurements offers 
only limited value for the assessment of the risk of postoperative AF. 
 
6.8. HIGH-RATE ATRIAL PACING TEST 
 We developed a new intra-operative screening test for identifying the patients at 
high risk for postoperative AF (IV). The intra-operative high-rate atrial-pacing test 
turned out to be useful tool for identifying patients at high risk for AF after CABG. 
AF may begin as a rapid atrial tachycardia from the pulmonary veins, with 
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tachycardia remodelling promoting the transition to multiple-circuit re-entry AF 
(Haissaguerre et al. 1998, Hobbs et al. 1999). Re-entry and atrial fibrillation is 
facilitated when adjacent atrial regions have widely disparate refractory periods (Sato 
et al. 1992, Cox 1993). Our study suggests that high-rate atrial pacing mimics the 
rapid atrial tachycardia and thus identifies the patients vulnerable to AF. Atrial pacing 
with high rate induces AF in the presence of increased dispersion of refractoriness i.e. 
where some parts of atrial tissue are repolarised while the adjacent tissue is still 
depolarised. 
 Only one other study has tried intraoperatively to predict the risk of AF after 
CABG (Lowe et al. 1991). In contrast to our study, Lowe et al. did not use high-rate 
pacing but stimulated the mid-right atrium with a bipolar probe and alternating 
current to induce AF. The test induced AF in 36 of 50 patients. The sensitivity and 
negative predictive values of their test were better than those in our test (0.94 vs. 0.61 
and 0.93 vs. 0.79, respectively). On the other hand, in our study, the specificity, 
positive predictive value, and accuracy were better (0.81 vs. 0.41, 0.63 vs. 0.47, and 
0.74 vs. 0.60, respectively). This suggests, that the alternating current protocol 
employed in the other study may be more aggressive and results in too many false-
positive cases and, therefore, it is not as suitable as the present protocol for the 
identification of patients with a need of anti-arrhythmic therapy. 
 The preoperative analysis of signal-averaged P-wave duration gives sensitivity 
of 0.63-0.86, specificity of 0.39-0.88, positive predictive value 0.34-0.65 and 
negative predictive value 0.82-0.87 in identifying the patients developing AF after 
CABG (Table 4). Thus, the result of intraoperative high-rate pacing test (IV), 
sensitivity 0.61, specificity 0.81, positive predictive value 0.63 and negative 
predictive value 0.79 are comparable with the predictive value of signal average P-
wave duration. 
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7.       SUMMARY AND CONCLUSIONS 
   AF is the most common arrhythmia CABG. It increases morbidity, resource 
utilisation, and costs of operative treatment. Prophylactic amiodarone administration 
and, perhaps, preventive pacing therapy reduce the incidence of AF after CABG. 
However, the routine use of these therapies for all patients undergoing CABG is not 
cost effective and may, in addition, cause unwelcome side-effects in some patients. 
The purpose our study was to find a reliable preoperative method for identifying 
patients at high risk for AF after CABG. 
 Data from 3,676 CABG patients were retrospectively analysed to create a 
logistic regression model to predict the risk of AF after CABG. The model was 
validated in 1,107 patients. Discrimination power of the model was not good enough 
for clinical use, since the area under ROC curve was 0.690. The negative and positive 
predicting value of the model was 0.72 and 0.55, respectively. 
 Short-term HRV was measured preoperatively in 92 elective CABG patients in 
standardised physiological conditions. No measured parameters of HRV analysis 
differed significantly between the patients who developed AF after CABG and those 
who remained in SR. 
 Atrial sizes were measured by preoperative echocardiography, and ANP and N-
ANP preoperative levels were measured in 88 elective CABG patients in order to 
analyse their role in predicting the risk of postoperative AF. A large left atrium 
associated with increased risk of postoperative AF. A high concentration of ANP and 
of N-ANP correlated with increased risk of postoperative AF, but they were not 
independent when adjusted for age. 
 A new intra-operative high rate atrial-pacing test was developed. It was tested in 
80 patients undergoing CABG. The positive and negative predictive values of the test 
(0.63 and 0.79, respectively) for postoperative AF were comparable with the results 
of other methods. No morbidity was related to the performance of pacing test. 
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On the basis of the present study following conclusions can be drawn: 
 
1. Old age, large BSA, low ejection fraction, preoperative digoxin use, and IABP 
or inotropic medication during the first 24 hours after CABG, are independent 
predictors of postoperative AF. However, a logistic regression model with these 
parameters is not accurate enough for clinical application. Postoperative AF is 
associated with an increased risk of postoperative stroke, severe gastrointestinal 
complications, readmission to ICU, and longer ICU and hospital stays. 
 
2. The patients at high risk of AF after CABG cannot be identified by preoperative 
short-term HRV analysis performed during standardised physiological conditions. 
 
3. Left atrial enlargement was independent predictor for postoperative AF after 
CABG. ANP and N-ANP were associated with age and did not independently 
predict postoperative AF. Furthermore, the wide variation of the peptide levels 
renders the implementation of this measure in a clinical setting impractical.  
 
4. The intraoperative high-rate atrial pacing test turned out to be simple, safe, and 
fast way to assess the patients at risk for AF after CABG. The diagnostic accuracy 
of this test seems to be sufficient to identify a group of patients to whom 
prophylactic treatment could be proactively targeted. 
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